Most patients come to us having already been quoted a number somewhere else, and the question they actually want answered is whether that number is fair.

So here it is, plainly.

Los Angeles fertility clinics publish IVF cycle prices between roughly $12,400 and $22,000. Most patients end up paying $17,000 to $30,000 for a single IVF cycle once fertility medications, anesthesia and the embryo transfer are added. All-inclusive IVF packages in LA start at $10,995.

The gap between those first two numbers is the whole problem. The price you’re quoted is almost never the price you pay, because stimulation medications, anesthesia, genetic testing, embryo freezing and the transfer itself are usually billed separately. One patient in a Los Angeles fertility forum put it the way most people eventually do: there are always things that pop up as extra costs along the way.

What follows is the full breakdown of IVF cost Los Angeles clinics quote in 2026, line by line, plus what a realistic course of IVF treatment costs rather than a single cycle, what California’s new insurance coverage rules do and don’t pay for, and the levers that genuinely bring the overall cost down.

IVF Cost in Los Angeles: What One Cycle Actually Costs

Here’s what the individual pieces of in vitro fertilization cost in Los Angeles, and which ones tend to sit inside a quoted package versus being billed on top.

What you're paying for	Typical Los Angeles range	Usually inside the quote?
Conventional IVF cycle (monitoring, egg retrieval, fertilization, embryo culture)	$12,400 to $21,945 published, $15,000 to $30,000+ all-in	Yes
All-inclusive Access IVF cycle	$10,995	Yes, fully inclusive
Mini IVF cycle	$7,000 to $18,000	Yes
Fertility medications, conventional protocol	$4,000 to $8,000	Almost never
Stimulation medications, mini IVF protocol	$700 to $2,700	Sometimes
Anesthesia for egg retrieval	$500 to $1,500	Often not
ICSI	$1,000 to $2,500	Sometimes bundled
Preimplantation genetic testing (PGT)	$3,000 to $7,000	Rarely
Frozen embryo transfer	$3,000 to $5,000 per transfer	No, billed per transfer
Embryo freezing	$500 to $1,000	No
Annual embryo storage	$500 to $1,000 per year	No
Pre-cycle testing and diagnostics	$100 to $3,700	No
Donor eggs	$14,000 low end, $25,000 to $40,000 typical	No

Ranges reflect published Los Angeles clinic pricing and what LA patients report paying. Our own pricing is confirmed in writing at consultation, before beginning treatment.

What the Base IVF Cycle Fee Covers

A standard IVF cycle fee in Southern California generally buys six things: ovarian stimulation monitoring, which means repeated bloodwork and ultrasound monitoring appointments across roughly two weeks; the egg retrieval itself; fertilization in the lab; embryo culture while the embryos develop; in many packages, one fresh embryo transfer; and the pregnancy test that follows it.

What it does not buy is the part that catches people out.

“One IVF cycle” isn’t a standardized unit. There’s no rule about what a clinic must include under that heading, which is why two LA quotes for the same phrase can differ by $10,000 without either clinic being dishonest. One clinic folds in ICSI and the transfer. Another prices the retrieval alone and bills every other step as it happens.

You can see this in the published pricing. A Los Angeles clinic listing IVF at $12,400 to $21,945 states plainly on the same page that the price excludes medications, anesthesia, cryo storage and genetic testing. That single sentence is the entire issue in miniature: a real price, honestly published, that still isn’t what you’ll pay.

The practical move is to ask for the quote itemized rather than as a package number. Specifically, ask what’s included for:

• Fertility medications and the trigger shot
• Anesthesia and any facility or operating room fee
• ICSI
• Genetic testing, and whether it’s priced per embryo or per batch
• Embryo freezing, and the first year of storage
• The first embryo transfer
• Each additional transfer after that

Is a $30,000 Quote Normal? How Los Angeles Compares

Short answer: yes, at the high end.

A $26,000 to $30,000 all-in quote from a Los Angeles clinic is expensive, but it isn’t an outlier and it isn’t a sign you’re being taken advantage of. It usually reflects a package with genetic testing and a transfer already folded in. LA patients comparing notes describe a fairly consistent picture: around $20,000 for a retrieval at one Encino clinic plus $3,000 to $4,000 in medications, roughly $19,000 for a round elsewhere plus $4,000 in medications and $5,000 per transfer, and one widely discussed Beverly Hills package at $26,000 covering retrieval, genetic testing, one transfer and facility fees, with medications estimated at another $6,000 on top.

Los Angeles does run expensive compared with IVF costs elsewhere in California, for reasons that have nothing to do with any individual clinic: lab overhead, cost of living, and a large donor pool that pushes donor-cycle pricing specifically. IVF also sits at the top of the range for fertility treatment costs generally, well above IUI or a medicated cycle, which is part of why the number lands as hard as it does.

But a $17,000 quote and a $30,000 quote can describe identical care. Before you compare two fertility clinics, convert both quotes to the same basis:

• Egg retrieval and lab fees
• Plus fertility medications
• Plus one embryo transfer
• Plus genetic testing, if you plan to do it

Compare those four-part totals. Comparing headline IVF packages tells you almost nothing.

The Line Items That Land On Top of the Quote

These are the costs that arrive after the package is agreed:

• Anesthesia and facility fees for the egg retrieval, $500 to $1,500
• ICSI, $1,000 to $2,500, where male factor infertility is diagnosed or a previous treatment cycle had poor fertilization
• Genetic testing, $3,000 to $7,000, usually priced per batch of embryos rather than per embryo
• Embryo freezing, $500 to $1,000, then $500 to $1,000 every year the embryos stay stored
• Each frozen embryo transfer, $3,000 to $5,000, plus its own medication cycle
• Pre-cycle testing for both partners, including hormone panels and a semen analysis
• Implantation or immune support protocols, where recommended

Of these, the transfer is the one that quietly reshapes a budget. The retrieval is a one-time cost. But if the first embryo transfer doesn’t result in a pregnancy, the second one is a fresh $3,000 to $5,000 plus medications, and so is the third. That makes frozen embryo transfer cost the single most underestimated line in an IVF budget.

Budget for more than one transfer from the beginning, and budget for the full course rather than the first cycle.

Quoted package vs realistic first-year cost (Los Angeles) Quoted package Plus medications Plus a second transfer $20,000 $26,000 $32,000Illustrative, built from published Los Angeles clinic pricing and patient-reported LA costs. Your figures will differ.

What a Full Course of IVF Costs, Not Just One Cycle

The price you can search for is the cost of a cycle. The cost that actually lands on your household is the cost to achieve pregnancy. A cycle that doesn’t work isn’t a discount.

Running that calculation takes three numbers: what a single IVF cycle costs, how many egg retrievals patients in your age band typically need, and what each additional transfer adds.

How Many Egg Retrievals It Usually Takes

The CDC collects outcome data from every reporting fertility clinic in the country through its National ART Surveillance System, and its figures are the right place to start because they’re independent of any clinic’s marketing.

In the 2022 national ART summary, the most recent reporting year available, 37.5% of assisted reproductive technology cycles nationally resulted in a live birth delivery. The average patient using ART was 36.3 years old.

Two things about that 37.5% matter for your budget.

First, it counts every cycle, including the 42.6% of cycles performed purely to bank eggs or embryos for later, which were never intended to achieve pregnancy that year. So it understates the odds for someone doing a treatment cycle with a transfer in mind.

Second, and more usefully, the CDC’s success rates for patients using their own eggs are cumulative. They include embryo transfers that happen within a year of the egg retrieval. That’s exactly the right way to think about cost, because it counts one retrieval and every transfer that follows it as a single attempt with a single price tag.

Success rates fall with age, steeply after the late thirties, and the CDC publishes them broken down by age band. Look up your own band rather than relying on an average built from everyone.

The CDC’s own caution is worth repeating, because it’s honest and it applies to every clinic including ours: average chances may not reflect what happens for an individual, and anyone considering IVF treatment should talk it through with a fertility specialist.

The budgeting conclusion is simple. If a meaningful share of patients need multiple cycles, a per-cycle price is a down payment rather than a total.

Running the Numbers on Your Own Budget

Here’s the arithmetic, using LA figures.

One conventional IVF cycle at $20,000, plus $6,000 in fertility medications, plus a first embryo transfer already included, comes to roughly $26,000. If that transfer doesn’t take, a second frozen embryo transfer at $4,000 plus its medications brings you to about $31,000. If you need a second egg retrieval, add most of the first number again.

Los Angeles patients describing full courses land in that territory consistently: roughly $34,000 for one retrieval, medications and two transfers, and around $35,000 for two retrievals, one transfer and all medications.

Run it in both directions before you choose a clinic, because the answer isn’t automatic:

• A lower per-cycle price that needs three attempts can cost more than a higher price that works on the first.
• It can also cost less, if the lower-priced protocol is the right one for your infertility diagnosis.
• You can’t tell which without putting your own age, diagnosis and ovarian reserve into the calculation.

The CDC publishes a free IVF Success Estimator that takes your own inputs and gives you an estimate independent of any clinic. It’s a good sanity check before you commit to a payment plan.

Then ask any clinic you’re considering one direct question: what happens financially if the first transfer doesn’t work.

What to Ask a Los Angeles Clinic About Its Own Results

Underneath the cost question is a different one. Will this clinic get me there in fewer cycles?

You don’t have to take anyone’s word for it. The CDC publishes success rates for individual fertility clinics alongside the national ones, searchable by location, so you can compare any Los Angeles clinic against the national numbers for your own age group.

When you’re on a consultation call, ask:

• What’s your live birth rate per egg retrieval for patients in my age group?
• Is that figure cumulative, meaning does it include the frozen transfers that follow?
• How many of your patients with my infertility diagnosis needed multiple cycles?

For context on our side: our IVF success rates run about twice the national cumulative average, we’ve helped build more than 3,000 families over 20+ years, and we’re SART certified, CAP and AAAHC accredited, and recognized by Newsweek among America’s Best Fertility Clinics for three consecutive years.

We can’t guarantee you a baby, and no clinic honestly can. What we can guarantee is a treatment plan built around your specific diagnosis, and a number you can plan around before you start.

What Makes Your IVF Cost More or Less Than the LA Average

Now that you know the range and the real total, here’s what determines where you personally land in it.

The Type of IVF Cycle You Do

This is the largest single swing in price, and many patients don’t know the options exist.

Cycle type	Los Angeles cost	Medications	Who it tends to suit
Conventional IVF	$15,000 to $30,000+	$4,000 to $8,000	Most patients, when maximum eggs per retrieval matters
Mini IVF	$7,000 to $18,000	$700 to $2,700	Some patients with low ovarian reserve, or who want fewer side effects
Access IVF	$10,995 all-inclusive	Not included	First-time IVF patients who've already tried less invasive fertility treatments

Conventional IVF, sometimes called traditional IVF, uses full-dose ovarian stimulation to produce multiple eggs in one retrieval. It costs the most in stimulation medications and generally produces the most eggs, which is why traditional IVF treatments remain the default for most patients.

Mini IVF uses low-dose stimulation. Fewer eggs per retrieval, but the medication bill drops from thousands to hundreds, which is where most of the saving comes from and why mini IVF costs sit so far below a conventional cycle.

Natural IVF goes further still, with little or no stimulation and typically one egg per cycle. Estimates put it at $3,000 to $6,000 per treatment cycle in California. Two catches matter for the overall cost. Fewer eggs per cycle usually means multiple cycles. And because there’s little or no medication holding the cycle in check, premature ovulation can cancel a retrieval before it happens, and a cancelled cycle still costs you monitoring appointments and time.

Access IVF is our all-inclusive option at $10,995, covering clinic ultrasound monitoring, bloodwork, egg retrieval, ICSI fertilization and a fresh embryo transfer where it’s medically recommended. It’s not for everyone, and we’d rather say so upfront: it’s designed for patients who haven’t done IVF before and who have already tried less invasive fertility treatments without success.

Match the protocol to your diagnosis, not to the price tag. A low-dose cycle that produces too few eggs for your situation costs more across the full course, not less.

Genetic Testing, ICSI and the Other Add-Ons

Every add-on is a spending decision, and a few deserve more scrutiny than they usually get.

Preimplantation genetic testing for aneuploidy (PGT-A). PGT testing costs $3,000 to $7,000 in Los Angeles, and this one warrants a real conversation with your doctor rather than a checkbox on a price sheet. The American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology concluded, in their 2024 committee opinion on PGT-A, that the value of PGT-A as a routine screening test for all patients undergoing IVF has not been demonstrated. Recent multicenter randomized trials found pregnancy outcomes broadly similar between PGT-A and conventional IVF, and the societies describe its value in reducing miscarriage risk as unclear. It’s commonly offered, and there are individual situations where your physician may recommend it. But given the cost, ask why it’s being recommended for you specifically.

The fee normally splits in two: the embryo biopsy performed at the clinic, and the fee charged by the testing laboratory. Ask which half a quoted price refers to, because some IVF packages include the embryo biopsy and not the lab work.

PGT-M, which tests for a specific inherited condition a family carries, is a different test with a different purpose and a different evidence base. Don’t let the acronyms blur together.

ICSI. A single sperm injected directly into the egg, standard where male factor infertility is diagnosed or where a previous cycle had poor fertilization. ICSI costs $1,000 to $2,500, and some LA packages bundle it while others bill it separately, which on its own explains a couple of thousand dollars of difference between two quotes.

Embryo freezing and storage. Embryo freezing costs $500 to $1,000, then $500 to $1,000 a year to store. Easy to forget at signing and easy to feel later, since storage is the one fertility cost that recurs annually whether or not you’re in treatment.

Assisted hatching, extended embryo culture, implantation and immune support. These are quoted case by case. Assisted hatching involves thinning the outer layer of the embryo before transfer, and like the others it isn’t automatic. The question to ask about each is whether it’s recommended for your diagnosis or standard on the price sheet.

Donor Eggs, Donor Sperm and Building a Family Without a Partner

Not everyone doing IVF is a couple using their own eggs and sperm, and the cost picture changes depending on the path.

Donor eggs. Egg donation is the largest add-on in reproductive medicine. One out-of-state clinic puts the range at around $14,000 at the low end and $25,000 to $40,000 as typical, though that clinic markets travel cycles and has an interest in how LA pricing looks, so treat it as a ballpark. Frozen donor egg cohorts generally cost less than a fresh dedicated donor cycle. Published Los Angeles figures put embryo freezing with donor eggs at $9,800 and up, and embryo banking with donor eggs at $19,550 and up.

Donor sperm adds purchase and screening fees, though the cycle fee itself generally doesn’t change based on whose sperm is used. Many patients assume using donor sperm makes IVF more expensive by definition. It doesn’t. It adds a separate, smaller line item.

Reciprocal IVF, where one partner provides the eggs and the other carries the pregnancy, is priced as a combined cycle across two people, so reciprocal IVF costs more in monitoring appointments and medication for the partner carrying.

Gestational surrogacy. The clinic-side fees for gestational surrogacy in Los Angeles are published at $7,300 to $12,150. That figure covers the clinic’s part of the IVF procedures only. Surrogate compensation, agency fees and legal fees are separate and are the larger share of the total.

Does Insurance Cover IVF in Los Angeles? What Changed in 2026

This is the section that decides whether you pay nothing or twenty-five thousand dollars, and it’s also the one where the most outdated information circulates.

Who California’s New IVF Law Covers, and Who It Leaves Out

California’s SB 729 was signed in 2024 with an original start date of July 1, 2025. That date was pushed back by budget legislation in June 2025. The mandate now applies to insurance plans issued, amended or renewed on or after January 1, 2026, and requires them to cover infertility diagnosis and treatment, including IVF. Several fertility pages still publish the old 2025 date, so check the date on anything you read about this.

January 1, 2026 also wasn’t the day IVF coverage switched on for everyone. Coverage begins at each plan’s own renewal date, which means two people at different employers can get completely different answers in the same month.

Covered: fully insured large group plans, meaning 101 or more employees, regulated by the California Department of Managed Health Care or the California Department of Insurance.

Not covered:

• Self-funded employer plans, which are governed by federal ERISA law and sit outside California’s authority. Plenty of large employers are self-funded, so headcount alone doesn’t answer the question.
• Small group insurance plans, where coverage has to be offered but not provided
• Individual and family market plans
• Medi-Cal and Medicare
• CalPERS members, deferred to July 1, 2027

One detail worth knowing if you’re building a family as a single parent or in a same-sex relationship: the law defines infertility to include a person’s inability to reproduce without medical intervention, whether alone or with a partner. It doesn’t require a period of heterosexual intercourse first. You aren’t excluded by definition.

What the Law Pays For: Three Retrievals, Unlimited Transfers

Where it applies, SB 729’s IVF coverage runs to three completed egg retrievals per person, with unlimited embryo transfers, in line with ASRM guidelines.

The unlimited transfers provision is the more valuable half, and it maps directly onto the arithmetic above. Transfers are the recurring cost that reshapes budgets, and three retrievals covers what many patients doing multiple cycles actually end up needing.

One caution. Covered isn’t the same as free. Deductibles, copays, coinsurance and out-of-network rules all still apply, and medication coverage sits under your pharmacy benefit, which can be an entirely separate question from your IVF benefit.

How to Find Out What Your Own Plan Will Pay

Run this checklist before your first cycle:

• Ask HR one question first: is our plan fully insured or self-funded? That single answer determines whether California’s mandate applies to you at all.
• Ask for the plan’s renewal date, not just the plan year.
• Get the infertility insurance coverage details in writing from your insurance company, including whether fertility medications are covered and under which benefit.
• Ask whether fertility benefits are administered separately. Many employers route them through a third party such as Progyny, WINFertility, Maven or Carrot, and you’ll want to know that name before you call anyone.
• Ask the clinic’s financial team to run a benefits check before you start, and to confirm which line items are billable to insurance and which are cash-pay only. Some discounted IVF packages can’t be billed to insurance at all.

Confirm the specifics with your plan administrator. Benefits language varies more than anyone expects.

If you’ve worked through that list and found you’re not covered, or covered for less than you hoped, you’re in the same position as most people reading this. The next section is where the remaining levers are.

How to Lower the Cost of IVF in Los Angeles

Lower-Cost Cycle Options at an LA Clinic

The most direct lever is the one covered above: Access IVF at $10,995 all-inclusive, or Mini IVF at roughly $7,000 to $18,000 depending on protocol.

All-inclusive means the line items from the table above are already inside the number. No separate anesthesia bill, no ICSI surcharge, no surprise at the embryo transfer. That transparency is the specific thing LA patients say they can’t get, and it’s a deliberate choice on our part.

The caveat is the same one as before: a lower-cost cycle only saves you money if it’s clinically right for you.

Multi-Cycle IVF Packages and Refund Programs

Several LA clinics offer packages where you pay up front for multiple cycles, or pay a premium for a program that refunds part of the fee if there’s no pregnancy after the final cycle.

They can genuinely reduce the overall cost for patients likely to need more than one cycle. They’re essentially insurance you buy against your own odds. They also cost more up front than a single IVF cycle, so a patient who succeeds on the first attempt pays more than they needed to, and they carry age and diagnosis eligibility criteria that not everyone meets.

Before signing one, ask:

• What counts as a completed treatment cycle?
• What percentage is refunded, and when?
• What disqualifies me partway through?
• Are fertility medications inside or outside the package?

Financing, HSA and FSA Dollars, and Grants

The fertility financing options available to Southern California patients vary by lender rather than being one market rate. Published examples from LA clinic pages include loans of $2,000 to $40,000 over 24 to 84 months from one lender, and $3,000 to $50,000 over 6 to 60 months from another. Financing is a real option with a real cost of borrowing attached, so compare the total repaid, not the monthly payment.

HSA and FSA dollars cut the bill by your marginal tax rate. IRS Publication 502 lists, under Fertility Enhancement, “procedures such as in vitro fertilization (including temporary storage of eggs or sperm)” as an includable medical expense. That means IVF treatment is generally payable with pre-tax dollars, which saves you your marginal rate on the whole bill. Note the word temporary: ongoing annual embryo storage is a different question. Confirm the specifics with your plan administrator, and treat this as general information rather than tax advice.

Grants exist and are worth applying for, but set your expectations. They’re a contribution toward a cycle rather than a funding plan for one.

Where to Save on Fertility Medications

Fertility medications are the largest uncovered line item at $4,000 to $8,000 on a conventional protocol, which makes them the highest-yield place to save.

• Compare specialty fertility pharmacies instead of defaulting to the first name you’re given. Pricing on identical drugs varies more than you’d think.
• Ask your clinic’s financial coordinator which manufacturer discount or assistance programs your specific protocol qualifies for.
• Check whether post-transfer support medications fall under your standard pharmacy benefit. They sometimes do, even when stimulation medications don’t.
• Ask your physician whether the protocol has a lower-cost equivalent that doesn’t compromise the cycle.

One honest caution, because it comes up in every patient forum: some people buy medications overseas or second-hand. The risks are real and specific, covering storage temperature, cold chain and authenticity, and a compromised drug can cost you a whole cycle. Agree any medication plan with your doctor first.

IVF Costs Stop Being Frightening Once They Stop Being a Guess

A single IVF cycle in Los Angeles runs $12,400 to $22,000 on published price lists and $17,000 to $30,000 in practice. Fertility medications and repeat transfers are the two line items that most often break a budget. California’s new mandate helps a narrower group than most people assume, and the first thing to check isn’t your employer’s size but whether the plan is self-funded. And the number that actually matters is what a full course of IVF treatment costs, not what one line on a price sheet says.

A price you can’t plan around isn’t really a price. What changes your financial position isn’t hunting for the cheapest cycle. It’s getting an accurate infertility diagnosis, matching the protocol to it, and seeing every number in writing before beginning treatment. High quality fertility care shouldn’t depend on being able to absorb a surprise bill.

That’s what a consultation with us is for. You’ll get itemized costs for your specific situation, a benefits check run against your actual insurance plan, and a treatment plan built around your diagnosis rather than a package we sell to everyone. Our IVF success rates run about twice the national cumulative average, we’ve helped build more than 3,000 families over 20+ years, and we’re recognized by Newsweek among America’s Best Fertility Clinics for three consecutive years.

We can’t promise you a baby, but we can promise you the most advanced, personalized care in reproductive medicine to maximize your chance of one, and a number you can actually plan around.

Request an appointment with our IVF specialists in Los Angeles.

Ever wondered what the difference between PGT-A and PGT-M is, and if/why you need both?

Both are preimplantation genetic testing, but they don’t cover for each other. A clean PGT-A result says nothing about inherited disease, and a clean PGT-M result says nothing about chromosomes. And neither can promise you a healthy pregnancy or a baby.

PGT-A screens every embryo for the right number of chromosomes. PGT-M tests embryos for one specific inherited gene mutation you already know about.

Most IVF patients are offered PGT-A. You need PGT-M only if carrier screening or family history has flagged a specific genetic disease.

This article explains what each test looks for, how to tell which one applies to you, and what the evidence says about running them together, including why your age changes that answer more than anything else does.

PGT-A vs PGT-M: The Differences at a Glance

	PGT-A	PGT-M
What it looks for	Chromosome count across all 24 chromosome types	One named single gene mutation
Type of test	Screening, sorts embryos by probability	Diagnostic, a yes or no on that one mutation
Where the problem came from	Random error, more common with maternal age	Inherited, already present in the family
What triggers it	Age, recurrent miscarriage, failed IVF cycles	A carrier screening result or known family history
Lab preparation	Runs off the shelf	Needs a custom probe built for your family's exact mutation before the cycle starts
What a "pass" means	Chromosome count looked normal. Says nothing about inherited disease	Does not carry that one mutation. Says nothing about chromosomes

Every difference in that table comes out of one distinction: PGT-A sorts your embryos by probability, PGT-M gives a yes or no on one named mutation. Preimplantation genetic testing (PGT) is the umbrella term covering both, which is part of why they get confused in the first place.

That distinction also explains the misunderstanding we correct most often in consultations. Euploid doesn’t mean healthy. A normal chromosome count says nothing about the genetic abnormalities PGT-M is built to find.

PGT-M can’t start until the genetics lab builds a test for your exact mutation, and that build needs DNA from the genetic parents, sometimes from affected relatives too. Because the build is priced separately from the analysis, it’s the biggest reason PGT testing costs within an IVF cycle vary so much from one patient to the next.

If you’re using a donor egg or donor sperm, the probe is built around whoever provided the genetic material, so we need the donor’s carrier status before your cycle rather than during it. Reputable donor programs screen for this, and it’s one of the first things we confirm when someone plans an egg donation cycle with a known family mutation. It’s the step most likely to hold up a timeline when nobody thought to ask.

What PGT-A Tests For

Its full name is preimplantation genetic testing for aneuploidy (PGT-A). You’ll also see it called aneuploidy screening, or PGS, the name it went by before. It counts the embryo’s chromosomes to check the number is right.

The arithmetic confuses almost everyone, because different clinics quote different numbers. PGT-A analyses all 24 chromosome types that exist in humans: numbers 1 through 22, plus the X and Y sex chromosomes. Any single embryo carries 23 pairs, 46 chromosomes in total.

Aneuploid is the word you’ll hear on your results call. It means an embryo has an extra chromosome or is missing one. These chromosomal abnormalities are the same mechanism behind Down syndrome and Turner syndrome, which is part of why the term lands so hard when nobody has explained it first.

These errors are almost always random. They didn’t come from your family, and they aren’t anyone’s fault. They become more common as egg quality declines with age, which is a leading reason cycles fail in older patients.

Patients are usually surprised by the next part. Across the IVF population, PGT-A has not been shown to raise cumulative live birth rates. It can screen embryos and rank them. It can’t improve them. The American Society for Reproductive Medicine’s 2024 guidance found recent trials produced similar pregnancy outcomes with and without the test, and concluded that “the value of PGT-A to lower the risk of clinical miscarriage is also unclear.” Where it does help is in ordering your transfers, and in one group in particular, covered further down.

What PGT-M Tests For

If you’re here for PGT-M, you already know the name of the thing you’re trying to avoid. That’s what makes this test different from the other one.

Its full name is preimplantation genetic testing for monogenic conditions, and it was called preimplantation genetic diagnosis, or PGD, until the terminology changed. It looks for single gene disorders already known to run in the family, which means the lab has to know exactly what it’s hunting before it can hunt. PGT-M can’t find a disease nobody has named.

Patients most often come to us about cystic fibrosis, Tay-Sachs disease, sickle cell anemia, spinal muscular atrophy, Huntington’s disease, hemophilia, Duchenne muscular dystrophy and thalassemia, along with BRCA1 and BRCA2, which carry an increased risk of breast and ovarian cancer. If a condition has a known, named mutation, a probe can usually be built to identify embryos that carry it.

How many of your embryos are likely to be affected depends on how these genetic conditions are inherited:

• Autosomal recessive, where both genetic parents carry it: roughly 25% of embryos affected.
• Autosomal dominant, where one parent carries it: roughly 50% affected.
• Sex-linked, such as Duchenne muscular dystrophy or hemophilia: roughly 50% of male embryos affected.

If you carry a dominant mutation, expect around half your embryos to be affected before chromosome testing enters the picture at all. We tell patients that number before retrieval rather than after, because it changes how many cycles you plan for, and because nobody should learn it on the phone in the middle of a hard week.

One limit to know now rather than later: PGT-M is highly accurate but not infallible. Misdiagnosis after PGT-M has been reported at 0.07%, 12 cases across 2,538 cycles, and it is why ASRM and SART recommend you be offered confirmatory prenatal testing in a pregnancy conceived after PGT-M. We’ll raise that with you at the time.

Which Test Applies to You

When PGT-A Is the Right Test

PGT-A comes up in four situations:

• Advanced maternal age, where aneuploidy rises as egg quality declines.
• Recurrent or unexplained miscarriage, with a caveat below that we think you should read.
• Unexplained IVF failure, whether that means failed cycles or failed transfers.
• A known chromosomal translocation, Robertsonian or reciprocal, which usually points to PGT-SR instead.

Meeting one of those doesn’t settle whether you’re eligible for PGT-A, but it’s where the conversation starts.

The miscarriage caveat is the one nobody mentions. ASRM’s 2026 guidance on recurrent pregnancy loss puts aneuploidy behind roughly 50 to 60% of first-trimester miscarriages. But compared with someone who has had a single loss, patients with recurrent loss are more likely to be having euploid miscarriages, where the chromosomes were normal. In the group most often sent for PGT-A, chromosomes turn out to be the explanation less often than that headline number suggests. That makes a proper recurrent pregnancy loss workup more useful than another test.

PGT-A is the default add-on almost everywhere. We don’t treat it that way. ASRM’s 2024 review found the clearest signal in older patients: a post hoc analysis of the STAR trial showed higher ongoing pregnancy rates per embryo transfer in the 35 to 40 group, though the advantage did not hold when measured from the start of the cycle rather than from transfer. For women over 37, ASRM cites one study putting the number needed to treat at 21 retrieval cycles, or 35 embryo transfers, for one additional live birth. That is a real benefit and a demanding one. Not everyone needs IVF, and not everyone doing IVF needs PGT-A.

When PGT-M Is the Right Test

PGT-M applies when you already know what you’re looking for. That usually means one of three things:

• Carrier screening found the same recessive mutation on both sides.
• You carry a dominant mutation, whether or not it has affected your own health.
• There’s a known genetic disease in your family, or you already have a child with an inherited condition.

PGT-M is not a general safety net. It targets specific genetic disorders you have already named, and it answers nothing beyond them.

One group deserves a direct word. If you’re here because of BRCA1 or BRCA2, you may be perfectly fertile. You’re doing IVF for access to the testing, not because you can’t conceive, and that’s a completely legitimate reason to be sitting in our office.

What Carrier Screening Does Not Catch

Standard expanded carrier screening panels are built around autosomal recessive and X-linked conditions. Autosomal dominant conditions sit outside what they were designed to find.

ACMG’s Tier 3 panel, the one it recommends for anyone planning a pregnancy, covers 113 genes: 97 autosomal recessive disorders and 16 X-linked.

The logic behind leaving dominant conditions out is that anyone carrying one would already know, because it usually shows up in the family. That holds most of the time. It fails if you were adopted, if your family is small or you’re out of touch with it, if a condition can be carried without ever causing symptoms, or if the mutation started with you.

A clean carrier screening result rules out a specific list of recessive and X-linked conditions. It isn’t an all-clear on everything else, because the panel never looked. Genetic screening only finds what it was built to find. If there’s a pattern in your family that yours never explained, raise it with a fertility specialist before you build embryos. That conversation costs nothing and we’d rather have it early.

When You Need PGT-SR Instead

Some patients comparing PGT-A and PGT-M are choosing between the wrong two options.

PGT-SR covers structural rearrangements. If you carry a balanced translocation or inversion, all your genetic material is present but arranged differently, and you’re probably healthy yourself because nothing is missing. You produce embryos that are often unbalanced, though, and the problem usually surfaces as repeated miscarriage rather than as anything wrong with your own health.

PGT-A counts chromosomes. PGT-SR checks how they’re arranged, which is a different question entirely. If you’re a translocation carrier, counting alone won’t tell you what you need to know.

Do You Need Both PGT-A and PGT-M?

One Biopsy Covers Both Tests

The fear is a second biopsy. There isn’t one. A single biopsy sample covers both analyses.

The PGT process is the same either way, and it runs inside a standard in vitro fertilization cycle. We grow your embryos to the blastocyst stage, day 5 or 6, then take a few cells from the trophectoderm, the outer layer that becomes the placenta rather than the inner cell mass that becomes the baby. That sample goes to the genetics lab for genetic analysis while we freeze the embryos by vitrification. You come back for a frozen embryo transfer once the genetic status of each embryo is known.

Sequential testing is an option worth raising with us: PGT-M first, then PGT-A on only the embryos that pass. Same single biopsy, lower total spend when you expect a large share of embryos to be affected. The trade-off is turnaround, closer to a month than two weeks, and not every genetics lab offers it. Ask about it if you’re carrying a dominant mutation and bracing for half your embryos to be ruled out.

The Case for Adding PGT-A

The strongest argument is that you’re already biopsying. Adding PGT-A is an analysis fee, not a second procedure.

What it’s meant to buy is fewer transfers that were never going to work. A transfer that fails costs you a month, a medicated cycle, and a very hard week. Sparing you one of those is supportable. Preventing a miscarriage you would otherwise have had is not, and ASRM says so itself.

If you end up with several normal embryos, PGT-A tells us which to transfer first. That ordering is the actual product.

You should hear the other half before you decide. Two large registry analyses associate PGT-A with lower cumulative live birth rates in routine practice, not higher. One drew on 133,494 US cycles in patients aged 40 and under. The other covered 111,975 UK treatment episodes, of which 2,243 involved PGT-A. Both are retrospective, so neither proves cause. The benefit is genuinely contested, which is exactly why we decide this one patient at a time.

The Case Against, and Why Your Age Changes the Answer

ASRM’s 2024 committee opinion is direct: “At present, however, the routine use of blastocyst biopsy with aneuploidy testing in all infertile patients undergoing IVF treatment cannot be recommended.”

For PGT-M patients specifically, a 2022 analysis in the Journal of Assisted Reproduction and Genetics went further, concluding that PGT-M without PGT-A is preferred to achieve an unaffected live birth. It’s a single-author paper rather than a professional body position, so it carries less weight than ASRM, but it addresses this exact question.

Its argument rests on the observation that PGT-M patients skew young, often under 35, an age where aneuploidy is less common. If that describes you, the miscarriage risk PGT-A is meant to reduce is already low. Against that small gain sits a real cost: discarding an embryo on an abnormal result that didn’t reflect what that embryo could have become.

That cost mostly lives in mosaicism, and you should understand it before you consent to anything. A biopsy reads a handful of cells and infers the whole embryo from them. Embryos can be mosaic, carrying both normal and abnormal cells, so the cells sampled may not represent the embryo they came from. A mosaic result isn’t a clean pass or fail. It’s a maybe, delivered about an embryo you may have very few of. ASRM issued separate guidance in 2023 on managing mosaic results, and clinics still differ in how they classify these embryos and whether they’ll offer one for transfer. Ask yours directly. Our PGT specialists will give you our policy before you consent to anything, not after a result forces the question.

If you’re under 35, carrying a known mutation, with good ovarian reserve and no history of loss, adding PGT-A is a judgment call rather than an automatic yes. The case gets stronger with age, and with failed transfers nobody has been able to explain. It cuts the other way if diminished ovarian reserve has left you with two or three embryos, because discarding one on an uncertain result costs you proportionally more. And it gets weaker if your history is recurrent miscarriage, for the reason we covered earlier.

This is an open scientific question. Anyone who answers it confidently in either direction is telling you more than the evidence knows.

Your Genetics Are Specific. Your Testing Plan Should Be Too.

Four questions to ask any clinic before you consent to testing:

• How do you classify and handle mosaic embryos, and would you offer one for transfer?
• Can PGT-M and PGT-A run sequentially off the same biopsy here, and what does that do to turnaround?
• How long does building the custom PGT-M probe take, and whose DNA samples do you need?
• Given my age, my ovarian reserve and my history, what does the evidence say about PGT-A adding value for me?

We welcome all four, and the fourth one especially. Twenty years and more than 3,000 babies is what lets us answer it from our own outcomes rather than from the literature alone. Our IVF success rates run at roughly twice the national cumulative average, we’re CAP and AAAHC accredited and a SART member clinic, and Newsweek named us one of America’s Best Fertility Clinics in 2023 and 2024.

Book an appointment with our team. Our fertility specialists will go through your carrier screening results and your medical history, and tell you which testing actually fits your cycle.

 

 

You had your tubes tied. At the time, you were sure. Now you want another baby, and the first thing standing in your way is the bill.

The honest answer: in most cases, health insurance does not cover tubal reversal. Insurance companies classify it as an elective procedure rather than a medically necessary one, which puts it outside standard coverage. But “most cases” is not “all cases.” And the difference between a denial and an approval usually has less to do with which insurance company you have than with how your surgery gets coded and documented.

Below is what most plans actually do, the situations where coverage does happen, the exact questions and codes to use when you call your insurance company, and what your options are if the answer is still no. Coverage varies by policy and by state, so a generic answer is worth very little here. The point of this article is to get you a definitive one for your plan.

Most Health Insurance Plans Do Not Cover Tubal Reversal

Why Insurance Companies Classify Tubal Reversal as Elective

To an insurance company, a tubal ligation is a form of birth control you chose. Reversal surgery reconnects the fallopian tubes and restores fertility. It doesn’t treat a disease. That one distinction is what pushes tubal reversal surgery out of standard coverage and into the elective category: a non-urgent surgical procedure that can be scheduled in advance.

The argument you’ll hear, sometimes in exactly these words, is that you elected the original sterilization, so undoing it is a personal choice rather than a medical need. That is a cold thing to be told when you’re sitting in a doctor’s office trying to build your family. It is also, in fairness, the logic that nearly all health insurance companies in this country apply.

There’s an irony most patients notice eventually. The same plan that would have paid for your tubal ligation, and that will pay for your prenatal care if you get pregnant, draws the line at the procedure in the middle.

One more thing worth knowing before you call: many plans exclude infertility services and treatment as an entire category, and that is how infertility insurance coverage tends to be written. Your reversal can get caught in that exclusion even if you have never once thought of yourself as an infertility patient.

What “Not Medically Necessary” Actually Means for Your Bill

“Not Medically Necessary” means your tubal reversal surgery is a self-pay procedure, and the surgeon’s fee, the facility, the anesthesia and the follow-up all land on you.

Before you accept that as your situation, three things are worth checking:

• Whether your case can honestly be documented as medically necessary
• What your policy specifically excludes, in writing
• What your plan will still pay for, even when it won’t pay for the surgery

We’ll go through each one.

When Insurance Does Cover a Tubal Reversal

Coverage here is uncommon, and nobody can honestly promise you that your insurance company will approve a claim. What you can influence is how accurate and how well documented your case is. That’s worth real money, so it’s worth understanding properly.

Medical Necessity: Pain, Bleeding, and Symptoms After a Tubal Ligation

The most common route to coverage runs through medical necessity. The principle is simple. If the reversal is performed to treat a diagnosed medical condition, and not purely to restore your fertility, it can meet an insurer’s definition of medically necessary.

Chronic pelvic pain is the finding that carries the most weight. It’s real, it can be evaluated, and it can be documented on its own merits, independent of whether you want to conceive.

Menstrual changes are more complicated. A lot of women notice heavier or more painful periods after a tubal ligation and reasonably conclude the surgery caused it. The evidence does not support that. Tubal sterilization itself has not been shown to alter menstrual patterns. What usually happens is simpler: many women stop hormonal birth control around the same time, and the pill had been suppressing the heavy, painful periods they now suddenly have back.

The same caution applies to “post tubal ligation syndrome,” which you’ll find all over the internet presented as a settled diagnosis. It isn’t one. We’re telling you this because it protects you: a claim built on a disputed syndrome is a weak claim, and an insurance company’s medical reviewer will know that. A claim built on documented pelvic pain, with a medical history behind it, is a far stronger one.

So bring a complete and honest medical history to your first appointment. Every symptom since your original tubal surgery, and when it started. Many women describe severe pain around ovulation that began only after their tubal ligation, and say nobody ever warned them it could happen. If that’s you, say so, in detail. The symptoms you’ve learned to live with and stopped mentioning are often the ones that matter here.

We won’t coach you to report symptoms you don’t have, and no honest doctor will. But if you have them, they belong in your chart.

The Coding Fork: Why Two Identical Patients Get Opposite Answers

Two women with the same insurance plan and the same symptoms can get opposite answers.

What usually decides it is the diagnosis code your claim is submitted under, far more than the name on your insurance card.

Two codes tell two completely different stories about the same operation:

Diagnosis code	What it says about your surgery
ICD-10 Z31.0 Encounter for reversal of previous sterilization	This is an elective reversal. Submitted this way, the claim lands inside the exclusion most plans write for sterilization reversal, and it is usually denied.
ICD-10 N97.1 Female infertility of tubal origin	This is a medical diagnosis. Submitted this way, with documentation behind it, many plans will at least evaluate the claim on its merits.

We are not telling you to ask your doctor to choose the code that gets you paid. That is insurance fraud, and any clinic willing to do it is a clinic you should walk out of.

What we are telling you is why the diagnosis matters so much. If a physician evaluates you and documents tubal factor infertility, or a condition arising from your ligation, then the claim reflects that reality and it has a case to make. If your situation is a straightforward elective reversal, it will be coded that way, and you should plan on paying for it yourself. Knowing which one you are, before you schedule anything, changes how you spend the next three months.

One question to ask any surgeon’s office before you book: how do you intend to code and submit this, and have you ever filed a medical necessity claim for a reversal? A practice that has never done it once is unlikely to do it well for you.

What Belongs in a Letter of Medical Necessity

If you have a case, your physician writes a letter of medical necessity to your insurance company. A strong one includes:

1. A detailed account of your symptoms and your diagnosis
2. An explanation of how the original tubal ligation is causing or contributing to your condition
3. A professional recommendation of reversal surgery as the appropriate treatment
4. Supporting test results, imaging, or medical records

Then follow up. Call the doctor’s office and the insurance company and confirm that every document actually arrived and is under review. Claims stall in silence, and nobody chases them for you.

Be prepared for this to be slow, tedious, and still end in a no. It happens. If it does, you have moves left, and they’re further down this page.

Does Medicaid or a Government Plan Cover Tubal Reversal?

In most cases, Medicaid does not cover tubal reversal, and the reasoning is the same one a private insurance company uses. Medicaid pays for medically necessary procedures, and a reversal performed to restore fertility sits outside that definition.

That isn’t the whole picture, though. Medicaid does typically cover other reproductive health services, including the tubal ligation itself as permanent birth control, pregnancy-related care such as prenatal and postnatal services, and in some states certain fertility diagnosis and treatment.

The detail that matters most is this: Medicaid benefits are set state by state. What’s true in California may not be true where you live, and a general answer online is close to useless. Call the number on your card and ask about the specific exclusions in the next section. That one call will tell you more than a week of searching.

How to Check Your Own Coverage in One Phone Call

Insurance coverage for a tubal ligation reversal is decided policy by policy, so the only answer that counts is the one your own insurer gives you. Work through this in order.

Start With the Exclusions, Not the Benefits

Ask what your policy excludes before you ask what it covers. Benefits language is vague and optimistic. Exclusion language is specific and binding, and it’s the language that decides your claim.

Ask your insurance company whether your plan excludes:

• Infertility testing
• Infertility services and treatment
• Reversal of tubal ligation, also called tubal reanastomosis

If reversal of tubal ligation is explicitly excluded in your plan documents, stop there. No amount of coding, documentation or appealing will change that outcome, and you have just saved yourself a month of paperwork. Skip to the section on paying for it directly, because that is now your path.

The Exact Codes to Read Out to Your Insurance Company

If reversal isn’t excluded, you have something to work with. Now get specific, because a representative answering “do you cover tubal reversal?” will give you a vague answer, and a representative reading a code will give you a real one.

Code	What it is
CPT 58750	Tubotubal anastomosis: the tubal reversal surgery itself
ICD-10 Z31.0	Encounter for reversal of previous sterilization
ICD-10 N97.1	Female infertility of tubal origin
ICD-10 Z98.51	Tubal ligation status, which documents your prior ligation
ICD-10 Z31.41	Encounter for fertility testing, often relevant to your pre-operative workup

Have your surgeon’s billing office confirm the current applicable codes before you rely on them, because coding standards get updated. And write down the representative’s name, the date and a reference number for every call you make. You will want them if you end up appealing.

Request Pre-Authorization, and Get It in Writing

Pre-authorization, sometimes called pre-approval, is your insurance company deciding in advance whether it will cover the surgical procedure. It’s how you avoid finding out after the fact, while you’re recovering from surgery and opening a bill you weren’t expecting.

Request it in writing, before you schedule anything, and have your doctor’s office submit the supporting documentation alongside it.

An Approval Letter Is Not the Same as Coverage

Approval does not always mean covered. A claim for an approved service can still be denied afterward if the service was excluded elsewhere in your policy, or otherwise not covered.

So when the letter arrives, read it for exclusions, not just for the word “approved.” Check both what the plan says it will pay and what it has quietly carved out. Get written confirmation of the amount your plan will cover and the amount that will be left to you. An approval letter you haven’t read to the end is not a guarantee of anything.

What Your Plan May Still Pay For, Even When the Surgery Is Not Covered

A denial on the surgery doesn’t mean the whole episode is out of pocket. Patients leave money behind here constantly, because they don’t think to ask about these pieces separately.

Consultation, Evaluation, and Pre Operative Testing

Policies that won’t cover the tubal surgery itself will sometimes still cover the evaluation and testing done beforehand. Your diagnostic workup, pelvic ultrasound and blood work are billed under different codes than the surgery, which means they get judged as separate questions.

So ask them as separate questions. Don’t accept one blanket no for your entire episode of care. Even a partial offset is worth ten minutes on hold.

Pregnancy Care After a Successful Reversal

If a pregnancy follows, your prenatal and postnatal care are standard covered benefits under most plans, including Medicaid.

It’s a strange shape for a benefit to take: the surgery may be the one part of this you pay for yourself. The care that comes after it is usually covered like any other pregnancy.

If the Answer Is No: How to Appeal It, and How to Plan For It

You Have the Right to Appeal a Denial

If you’re on a non-grandfathered health plan, federal rules give you two rights when your insurer denies a claim. First, an internal appeal, where you can require the insurance company to review its own decision. Second, if that fails, an external review by an independent third party, whose decision the plan has to honor.

Be strategic about it. An appeal has its best chance where there’s a genuine medical necessity case with documentation behind it. It has its worst chance where your policy carries an explicit exclusion for reversal of sterilization, because at that point the plan isn’t making a judgment call, it’s applying its own contract.

Start by asking for the denial reason in writing. The reason they give you determines whether you have anything to appeal with.

Paying With HSA or FSA Dollars

This option is written into the tax code.

IRS Publication 502, under “Fertility Enhancement,” lists this as a qualifying medical expense: “Surgery, including an operation to reverse prior surgery that prevented the person operated on from having children.”

That is a tubal reversal, named by the IRS.

Because it’s a qualified medical expense, it can generally be paid with pre-tax HSA or FSA dollars. Which means a procedure your insurance won’t touch can still be paid for with money that was never taxed, lowering what it really costs you by whatever your marginal rate happens to be. For a lot of patients this is the single largest saving available on the procedure.

Two caveats. Confirm with your HSA or FSA plan administrator first, because administrators can ask for documentation and plan rules differ. And this is not tax advice. If the amounts matter to you, ask someone who does taxes for a living.

Why an All Inclusive Price Beats a Low Quote

When you’re paying yourself, the number you’re quoted matters far less than what’s inside it.

At the California Center for Reproductive Health, our tubal reversal pricing is a fixed, all-inclusive $6,800, with no hidden fees. That covers:

• Initial consultation
• Preoperative visit, including pelvic ultrasound
• Semen analysis, if needed
• Preoperative blood work
• Operating room and anesthesia fees
• Surgical fees for Dr. Mor and his assistant surgeon, both double board-certified in Reproductive Endocrinology and Infertility, who perform every reversal together
• Postoperative visit

One line we’d rather tell you now than on the day: prior cesarean sections, or other extensive pelvic surgery, can lengthen your time in the operating room and may add a fee.

Prices do vary between surgeons, and a lower headline number is not always a lower bill. Ask any surgeon for a written, itemized, all-inclusive quote, then check whether the facility fee and the anesthesia are inside it or waiting for you afterward. That is the comparison that actually tells you something.

Financing and Payment Plans

If you need to spread the cost, the fertility financing options open to you are usually better than patients expect.

CCRH works with Sunfish, Kindbody and Carrot. Sunfish offers loans built for fertility treatment, up to $100,000, with monthly payments starting at $200, terms from two to seven years, no prepayment penalties and no origination fees. Carrot runs through employers, so it’s worth checking whether your workplace already offers a fertility benefit you aren’t using.

Grants exist too, though they’re competitive and slow. Baby Quest Foundation, the Cade Foundation and the Hope for Fertility Foundation all offer assistance, and they typically ask for proof of an infertility diagnosis, medical documentation and evidence of financial need. Apply early, because application windows close.

Whatever you sign, confirm three numbers first: the total repayment amount, the interest rate and the term.

Tied Tubes Do Not Have to Be the End of Your Story

Most health insurance plans won’t cover a tubal reversal, because they treat it as elective. The exceptions run through medical necessity, and they turn on what your doctor can honestly document and which diagnosis your claim is coded under. Your policy’s exclusion list, plus the five codes above, will get you a definitive answer in a single phone call. If you’re denied, you have the right to appeal. And if the answer is still no, HSA or FSA dollars, a fixed all-inclusive price and financing turn an intimidating number into something you can plan around.

The answer from your insurance company only settles half of it. A yes or a no from a claims representative tells you how you’ll pay. It tells you nothing about whether the surgery is right for you, how much healthy tube you have left to work with, or what your realistic chance of carrying a baby actually is. Those are the questions that decide whether any of this is worth doing, and no insurer is going to answer them for you.

That’s where a fertility center earns its place. At the California Center for Reproductive Health, our team will review your medical history and your symptoms, tell you honestly whether your situation supports a medical necessity claim or whether you should plan to self-pay, and give you a written all-inclusive price so you know exactly what you’re choosing between. Dr. Mor and his assistant surgeon are both double board-certified in reproductive endocrinology and infertility, and they operate on every reversal together. We’re confident enough in that work to put it in writing: if you don’t get pregnant within 12 months of your tubal reversal surgery, we’ll credit you $3,000 toward a standard IVF cycle.

What we won’t do is promise you a baby, or promise you that your insurance company will say yes. We can’t, and anyone who does is selling you something. Book a consultation with our tubal reversal specialists and start with a straight answer instead of another call to your insurer.

In our experience, most patients wait longer than they should to see a fertility specialist. Usually it’s because no one ever told them what the actual threshold is.

So here it is, plainly.

If you’re under 35, it’s worth seeing a fertility doctor after 12 months of trying to conceive. If you’re 35 to 39, after six months. If you’re 40 or older, it’s reasonable to come in as soon as you decide to try.

Age aside, some signs mean you shouldn’t wait at all: irregular periods, a diagnosis like PCOS or endometriosis, two or more miscarriages, or a known problem with sperm.

These timelines exist for a reason. Fertility declines as you get older, gradually through your early 30s and more steeply after 35. The months spent waiting are not neutral.

But coming in early isn’t about rushing into treatment. It’s about understanding where you stand while you still have the most options in front of you.

One more thing, because it’s the fear that keeps people away. Seeing a specialist is not the same as starting in vitro fertilization. Many of the people we see aren’t infertile at all.

Some are building a family as a single parent or in a same sex relationship. Some want to protect their options before a medical treatment. Some simply want a clear read on where they stand. For those who are struggling to get pregnant, an assessment usually points to a simpler next step long before IVF enters the conversation.

How Long to Try Before Seeing a Fertility Specialist

Knowing when to see a fertility specialist comes down to two numbers: how old you are, and how long you’ve been trying.

Those are the first things a fertility doctor will ask, so start there.

Your age	When to come in
Under 35	After 12 months of trying
35 to 39	After 6 months of trying
40 or older	Right away, as soon as you decide to try

That clock assumes regular, well-timed, unprotected intercourse. In clinical terms, infertility means not getting pregnant after 12 months of regular, unprotected intercourse, or after six months if you’re 35 or older.

Why does the window narrow with age? Both the number of eggs and their quality fall over time, slowly through your 20s and early 30s, then faster. Time on the clock is not free.

Under 35: After About 12 Months of Trying

A healthy couple under 35, having regular unprotected sex, has roughly a 20 to 25% chance of getting pregnant each cycle. About 85% conceive within a year, and most women under 35 reach a successful pregnancy without any help at all.

Chance of conceiving naturally (couples under 35) 3 months 6 months 12 months 57% 72% 85%Cumulative odds of pregnancy for healthy couples under 35. Source: clinical averages (ASRM).

That’s why 12 months is the marker. It’s the point where the odds suggest something may be worth looking into, not a sign you’ve done anything wrong. Conception simply takes most couples the better part of a year.

A couple of things are worth knowing during that year.

The benchmark is 12 months of trying, not 12 perfectly timed cycles. Don’t talk yourself out of help over a few mistimed months.

And the under-35 timeline assumes everything else is normal. If any warning sign in the next section applies to you, the year-long clock no longer does.

This is also the window to handle the lifestyle factors that matter: weight, smoking, alcohol, and knowing roughly when you ovulate. Small lifestyle changes here can matter more than people expect.

35 to 39: After Six Months

At 35, the math changes enough that the recommended window is cut in half.

Half a year of trying without success is the point to book a consultation, not to give it a few more months and see. If you’re 37 and half a year has gone by, that’s your signal.

Many clinics will also start basic testing at this stage, even when nothing obvious is wrong, because the testing itself is time-sensitive. A hormone panel, an AMH level to gauge ovarian reserve, and a basic check of the male partner give you a baseline while you still have room to act on it.

40 and Over: Don’t Wait, Seek Evaluation Right Away

At 40 and beyond, the advice is simple: come in right away, ideally when you first decide to try rather than after a waiting period.

Ovarian reserve and egg quality decline most steeply for women in their early 40s. A few months genuinely matters for the options available to you.

In practice, a doctor won’t ask you to prove a minimum stretch of trying at this point. Coming in early just means more of the menu is still open.

Signs You Should See a Fertility Specialist Sooner

The timelines above are the default. The signs below override them.

Any one of these is a reason to be seen before the 6 or 12 months are up, at any age. They apply to both partners, not just the one assumed to be the problem.

Sign	What it can point to
Irregular, absent, or very painful periods	Trouble ovulating, or fibroids
A known reproductive condition	Already a reason to come in
Two or more pregnancy losses	A treatable cause worth finding
Pelvic surgery, STIs, or tubal issues	Scarred or blocked tubes
Male-factor signs (abnormal result, ED)	A role in up to 40% of cases
A chronic condition, or early menopause in your mother	Higher risk worth checking

The rest of this section walks through each one.

Irregular Periods, Absent Cycles, or Severe Pain

Your cycle is one of the clearest windows into what’s going on.

Periods that are unpredictable, that go missing for stretches, or that fall outside the usual 21 to 35 day range often point to a problem with ovulation. If you’re not releasing an egg predictably, there’s nothing for the “keep trying” clock to count.

Pain belongs on this list too. Periods heavy enough to soak through protection, or painful enough to keep you home from work, are worth investigating. They can point to fibroids or other conditions.

If your cycles are erratic, start tracking them now. That record is one of the most useful things you can hand a doctor.

A Known Diagnosis Like PCOS or Endometriosis

If you already carry one of these diagnoses, you don’t owe the clock a year.

Polycystic ovary syndrome is one of the most common causes of irregular ovulation. Endometriosis can affect the pelvic organs and the quality of your eggs. Uterine fibroids and polyps fall in the same category, since the shape of the uterus matters for implantation.

These are exactly the conditions a reproductive endocrinologist manages day in and day out.

The reassuring part is that a known diagnosis often comes with a relatively simple path. Many women with this condition get pregnant on ovulation-inducing medication rather than anything more involved. Coming in early doesn’t mean an aggressive infertility treatment. It means matching the right help to a problem you already know you have.

Two or More Miscarriages

Recurrent pregnancy loss has a specific clinical meaning: two or more losses. That’s the current threshold from the American Society for Reproductive Medicine for an evaluation, regardless of your age or how long you’ve been trying.

The numbers are easy to misread, so here’s the context. Roughly 15 to 20% of known pregnancies end in miscarriage, and a single loss is common and usually not a sign of a fertility problem. (The “1 in 4” figure you often hear refers to the share of women who experience a miscarriage at some point, not the odds of any one pregnancy.)

Multiple miscarriages are far rarer. Fewer than 5% of women have two losses in a row, and only about 1% have three or more.

So reaching the threshold doesn’t mean something is definitely wrong. It does mean it’s worth looking for a treatable cause. Genetic abnormalities in the embryo are the single most common reason, and more often than people expect, the workup finds something that can be addressed.

Reproductive History Red Flags (Pelvic Surgery, STIs, Tubal or Uterine Issues)

Some risk factors won’t be solved by more time. Flag these up front rather than discover them after a year:

• Prior pelvic or abdominal surgery
• A history of sexually transmitted diseases or pelvic infection, which can scar or block the fallopian tubes
• A known tubal problem, or a previous ectopic pregnancy
• DES exposure, if it’s part of your medical history

These are largely mechanical or anatomical issues. A doctor will want to see what’s going on inside the uterus and tubes before the calendar runs further.

Bring whatever records you have: surgical notes, imaging, any prior tubal tests. They help determine the cause quickly.

When Sperm Is the Issue

It’s worth stating plainly, because it’s still routinely overlooked. Trouble conceiving traces back to the male partner about as often as the female partner, close to an even split, and the male side is a contributing factor in something like 30 to 40% of infertility cases.

Where infertility comes from ~1/3 Female factor ~1/3 Male factor ~1/3 Both or unexplained

The male partner is not a footnote here, and a semen analysis is one of the first and easiest tests there is.

A few things mean he should be checked now rather than later:

• A previous abnormal result
• Erectile dysfunction, or difficulty ejaculating
• A history of testicular injury, surgery, or an undescended testicle
• A varicocele
• Prior chemotherapy

Checking both partners early, instead of spending months looking at only one, is often what shortens the path. And many of these issues are treatable once a doctor knows what’s driving them.

A Chronic Health Condition or Family History That Affects Fertility

A handful of medical conditions are reason enough to involve a doctor sooner:

• Diabetes
• Thyroid disorders
• High blood pressure
• Autoimmune or genetic conditions
• Prior cancer treatment, such as chemotherapy or radiation

Any of these can affect your chances of conceiving or carrying a pregnancy. If you’re managing one, you don’t have to wait out the standard timeline to ask how it might factor in.

One signal gets missed more than the rest: your mother’s history. If she went through menopause early, you may be at higher risk for diminished ovarian reserve, a real fertility issue worth checking before you’ve spent a year wondering.

Reasons to See a Fertility Specialist That Have Nothing to Do With Infertility

Here’s something the standard advice rarely says out loud. A large share of the patients a fertility clinic sees were never failing at anything. They came in to plan, not to fix.

It’s as much about building a family on your own terms as it is about troubleshooting one that isn’t coming together.

Same-Sex Couples and Single Parents by Choice

If you’re in a same sex relationship or planning to parent on your own, a fertility doctor is the starting line, not a fallback after months of trying. There’s no waiting period to satisfy and nothing to rule out first.

A specialist maps out your fertility options for same-sex couples and single parents:

• Donor sperm or donor eggs
• IUI or IVF
• Reciprocal IVF, where one partner carries

The point of that first meeting is a plan that fits how you’re actually building your family, with the timing handled for you.

Freezing Eggs or Sperm to Protect Future Fertility

If parenthood isn’t now but might be later, fertility preservation works best the earlier you do it, while egg quality is higher. That’s the whole logic of freezing them young: you’re banking time for a future decision.

The process is shorter than most people assume, roughly two weeks from start to finish for a single cycle. Coming in to talk it through is about keeping options open, not committing to anything.

A Medical Diagnosis or Treatment That Could Affect Fertility

If you’re facing chemotherapy or radiation, gender-affirming care, or any treatment that can set back your chances, the time to see a doctor is before treatment begins: preserving eggs, sperm, or embryos before cancer treatment is possible. This is time-sensitive in a way most of these questions are not.

Known genetic conditions belong here too. Couples who carry a heritable condition sometimes come in specifically for preimplantation genetic testing, so they can plan around it rather than hope.

You Simply Want to Know Where Your Fertility Stands

You don’t need a problem to be worth a visit. A simple check, meaning basic ovarian reserve testing and a look at the male partner, gives you a baseline and a realistic sense of your timeline.

The honest case for it: what you learn at 30 changes the decisions you make at 33. This is information, not a diagnosis. For a lot of patients, it simply takes the guesswork out of planning. A good clinic treats that first visit as patient education as much as anything else.

Should You Start With Your OB/GYN or Go Straight to a Fertility Specialist?

This is one of the most common questions people have, and the answer depends on your situation.

The short version: a general OB/GYN handles routine reproductive health and can manage the first steps. A reproductive endocrinologist, a specialist who is board certified in reproductive endocrinology, works in reproductive medicine full-time.

Start with your OB/GYN if...	Go straight to a specialist if...
You're under 35 and recently started trying	You're 35 or older (at 40+, right away)
You have no warning signs	A red-flag sign applies
Your cycles look regular	You have a known ovulatory or pelvic condition
You just want the basic first steps	You've had repeat losses or several failed medicated cycles

When Your OB/GYN Is a Reasonable First Stop

If you’re under 35, recently started trying, and have none of the warning signs above, your OB/GYN is a sensible first stop. They can run tests to determine whether you’re ovulating, review your timing, check basic bloodwork, and in some cases start a first-line medication.

The caveat: capability varies. Some OB/GYNs won’t begin a workup until you hit the 12-month mark. If yours is moving slowly, or the situation is clearly beyond routine care, that’s your cue to move on.

When to Skip Ahead to a Reproductive Endocrinologist

Go straight to a specialist if any of these apply:

• You’re 35 or older, and certainly at 40+
• Any red-flag sign above fits you
• You have a known ovulatory disorder or pelvic condition
• You’ve had recurrent miscarriages

One group should pay particular attention, because they tend to wait the longest: people already trying with their OB/GYN.

If you’ve been through about three or more medicated cycles, Clomid or letrozole, without success, that’s a clear cue to move to a fertility specialist rather than run the same play again. Plenty of patients lose a year this way. You can refer yourself to most clinics, so when in doubt, an appointment costs you a visit, not your timeline.

The Sooner You Know, the More Options You Still Have

If there’s one thread running through all of this, it’s that acting earlier protects your choices.

The timelines tell you when to come in. The warning signs tell you when not to wait for them. And plenty of good reasons to get help have nothing to do with infertility at all.

What they share is simple: your odds and the range of treatment options both narrow with time. The sooner you understand your situation, the more of it stays in your hands.

A first consultation is information and a plan, usually starting with the simplest option that fits. Not everyone needs IVF, and finding out where you stand is rarely the dramatic step people brace for.

When you’re ready, you can book a new patient consultation with the California Center for Reproductive Health and usually be seen within about two weeks, no referral needed. You’ll get an honest read from a board certified team that has helped build more than 3,000 families, with IVF success rates that run roughly twice the national average.

Whatever brought you to this question, your next steps start with finding out where you stand. Request an appointment with our expert fertility team!

Freezing your eggs, sperm, or embryos is a way to keep the door open: a real shot at having biological children later, even when illness or timing is trying to close that window now.

For some people, that window is brutally short. A cancer diagnosis can come with two weeks to preserve your fertility before chemotherapy or radiation starts, and no one prepares you for that conversation. For others, the decision is calmer, made at 34 or 39 with one eye on the calendar and a stack of confusing price quotes.

Wherever you’re starting from, California is one of the best states to do this right now. A new law took effect in 2026, and an older one has protected people’s future fertility since 2020.

Here’s the part that changes everything: your reason for preserving decides what you pay. A medical need, like a treatment that could leave you infertile, gets covered far more often than an elective choice you make for timing. Understanding that one line can save you thousands of dollars.

This guide gives you the full picture: your options, who actually needs preservation, how California’s two laws apply to you, what it costs out of pocket, and how fast you need to move.

Fertility Preservation Options Available in California

There are five ways to preserve fertility, and they are not interchangeable. The right one comes down to your body, your timeline, and whether there is a partner or donor in the picture. California offers the full range of fertility preservation services, so here is the fast version, then the detail.

Method	Best for	How invasive	Time it takes	Rough CA cost
Egg freezing	People with ovaries delaying, or facing care	Hormone shots + retrieval	~2 weeks	$9,000-$13,000 + meds
Sperm banking	Anyone who produces sperm	None	Same day	A few hundred-$1,000
Embryo preservation	Couples, or people using donor sperm	Same as eggs	~2 weeks	$12,000-$20,000
Ovarian tissue	Children, or urgent cases that can't wait	Minor surgery	Days, no stimulation	Specialized centers
Testicular tissue	Prepubertal boys before treatment	Minor surgery, investigational	Days	Research programs

Egg Freezing (Oocyte Cryopreservation)

Egg freezing is what most people picture when they say they’re “preserving.” It’s for anyone with ovaries who wants to protect their fertility, whether you’re 33 and not ready, or you just learned that chemotherapy is coming.

The process takes about two weeks: hormone injections to ripen a batch of eggs, a short retrieval under light sedation, then flash-freezing (called vitrification) that locks them in time. Stored well, they can wait years.

Cost is the part nobody explains clearly. A single elective cycle runs roughly $9,000 to $13,000 before medications. Add $3,000 to $6,000 for the hormone medications, plus $500 to $1,000 a year to store what you collect. Most centers offer payment plans; UCSF, for example, advertises financing from about $150 a month.

One honest caveat: age affects how many eggs you collect and how many cycles you’ll need. The younger you start, the better your odds later. 

Sperm Banking

If you produce sperm, this is the easiest decision in the guide. Sperm banking is fast, painless, and cheap, and you can usually start the same day you call. That speed matters if cancer care is days away, or if you’re about to begin gender-affirming hormone therapy.

A sample is collected, checked, and stored, often across one or two visits. The cost is modest: a few hundred to around a thousand dollars up front, plus a small annual storage fee. Some health systems, including Kaiser, arrange banking through an outside cryobank rather than charging one in-house price, so ask how yours handles it. Dedicated facilities like California Cryobank do this too.

Embryo Preservation (Embryo Cryopreservation)

Embryo freezing starts the same way as egg preservation, then goes one step further: the eggs are fertilized with sperm (a partner’s or a donor’s) before they’re stored. For couples ready to build embryos now, it’s a strong option, and it leads straight into in vitro fertilization (IVF) when you’re ready to try, a treatment SB 729’s IVF coverage can make far more affordable.

The trade-off: an embryo needs a sperm source decided today, and stored embryos belong to both people who made them. That’s worth a frank conversation before you start, especially as a couple.

Ovarian and Testicular Tissue Preservation

These options exist for the people the others can’t help: children who haven’t gone through puberty, and adults whose care can’t wait the two weeks an egg cycle needs. Instead of preserving eggs or sperm, a surgeon removes and stores a small piece of reproductive tissue, sometimes without delaying cancer care at all.

The two sit at different stages. Ovarian tissue preservation is now an accepted technique that ASRM no longer calls experimental. Testicular tissue preservation, used mainly for prepubertal boys who aren’t producing sperm yet, is still investigational and offered largely through research programs. Both are concentrated at academic centers like UCSF and Stanford, so ask specifically whether a program provides them.

Ovarian Protection During Cancer Care

There’s also a way to shield your fertility during chemotherapy instead of storing anything: medications called GnRH agonists that quiet the ovaries, or shielding that protects them during radiation. Think of it as a seatbelt, not a spare tire. It can lower the damage, but it doesn’t replace preserving eggs or embryos, so most people who can will do both.

Who Should Consider Fertility Preservation

Fertility preservation isn’t only for cancer patients, and it isn’t only for women. Four groups benefit most, and the group you fall into does more than describe you. It largely decides whether insurance pays.

People Facing Cancer or Other Gonadotoxic Treatment

This is the group with the least time. Chemotherapy, radiation, and some surgeries can damage your fertility, sometimes for good, which is why fertility preservation for cancer patients has to happen before treatment starts. The window is real: leading California programs, including UCSF, see patients within 24 to 48 hours of a diagnosis and work closely with oncologists so preservation doesn’t delay cancer care.

There’s a silver lining. Because there’s a clear medical need, this is also the most likely to be paid for, which is exactly where the coverage section picks up.

People Planning Ahead (Elective and Age-Related)

Maybe you’re focused on your career, haven’t met the right person, or just know you want kids “later” but not now. Preserving eggs in your late 20s or early-to-mid 30s gives your future self better material to work with, because both the number and quality of eggs fall as you age. A specialist can read your ovarian reserve with two simple measures, an AMH blood test and an antral follicle count, and tell you where you stand.

Here’s the hard truth this group needs: an elective choice is the kind insurance is least likely to cover, because it isn’t tied to a medical condition. Budget for it, and read the coverage section closely, because there are exceptions.

Transgender and Nonbinary People Before Gender-Affirming Care

Gender-affirming hormone therapy and some surgeries can affect your ability to have biological children later. Preserving eggs or sperm beforehand keeps that option open without putting your transition on hold for long. Timing is the thing to get right, ideally before you start hormones, so map out your LGBTQ+ fertility options and raise it with your care team early rather than late.

People With Genetic or Medical Risk Factors

Some people preserve because their body, or their family history, is telling them to. That includes carriers of BRCA and other inherited cancer-risk genes who may have risk-reducing surgery, people with endometriosis or autoimmune conditions, and anyone with a family history of early menopause. Genetic counseling can help you weigh the odds.

A word of caution: a medical condition doesn’t automatically mean it’s paid for. Patients with serious conditions, severe endometriosis among them, are sometimes told their situation doesn’t clear the insurer’s bar. Know that going in, and get any medical justification in writing.

How California Law Covers Fertility Preservation

This is where almost every other page gets it half-right. California has two laws that touch fertility preservation, not one, and the line between “medically necessary” and elective care decides whether you pay nothing or everything. Let’s untangle it.

SB 729: California’s New Infertility and IVF Mandate (Effective 2026)

Senate Bill 729 is the rule making headlines. Starting January 1, 2026, it requires fully insured health plans at large employers (100 or more workers) to cover the diagnosis and treatment of infertility, including in vitro fertilization and medically necessary fertility preservation. In practice that means up to three completed egg retrievals, unlimited embryo transfers (when clinically appropriate), fertility medications, and the diagnostic testing and monitoring that go with them.

It also rewrote who counts as “infertile,” so same-sex couples and single parents by choice are covered for the first time. For many of them a surrogate is part of the plan, and SB 729’s surrogacy protections cover that route too. Coverage starts when your insurance plan renews on or after January 1, 2026, and state employees on CalPERS plans are included beginning July 1, 2027.

Medical Need vs Elective Choice: The Line That Decides Your Bill

This distinction decides your bill. The 2026 mandate covers preservation when there’s a medical need, the classic example being banking eggs or sperm before chemotherapy. It does not require coverage for an elective choice you make to buy yourself more time.

In real life, that line can sting. Preserving before cancer care clearly qualifies. Doing it because you’re 38 with severe endometriosis sometimes gets denied, even though it feels medical to you. Criteria vary by policy, and a doctor’s documentation of the medical need can be the deciding factor. So ask your clinic and insurer directly whether your situation meets their bar, and get the answer in writing before you start.

California’s Older Fertility Preservation Protection (SB 600)

Here’s what the headlines miss: California has protected cancer patients’ fertility since long before the 2026 mandate. A 2019 law called SB 600, in effect since January 1, 2020, made standard fertility preservation a basic covered health service whenever a medical treatment might cause infertility (the clinical term is iatrogenic infertility).

So the two protections stack. SB 600 has covered medical-need preservation for years; SB 729 now adds broad infertility and IVF coverage on top. If you’re facing chemo, you may already have a right under SB 600 even if the newer IVF rules don’t fit your situation.

One boundary to know: both apply only to California-regulated, fully insured plans. Neither one binds self-funded plans (the kind large employers run under federal ERISA rules), so even a cancer diagnosis doesn’t guarantee coverage if your plan is self-funded. Check directly.

Which Plans Are Covered and Which Aren’t

The fastest way to know if the law is on your side is to identify your plan type.

Covered:

• Fully insured large-group plans (100+ employees) regulated in California

Not covered, or not required to comply:

• Self-funded plans (common at big employers, and easy to mistake for regular insurance)
• Small-group plans (under 100 employees)
• Individual and family marketplace policies
• Medi-Cal and Medicare
• Out-of-state policies
• Religious employers
• Any plan that hasn’t yet reached its 2026 renewal date

The self-funded trap catches people off guard. You can work for a household-name employer with excellent benefits and still fall outside the mandate, simply because the company funds the plan itself. Company size won’t tell you. Funding structure will.

How to Find Out If You’re Actually Covered

One hour on the phone can save you five figures. Here’s the call list:

1. Ask your HR department two things: is the plan fully insured or self-funded, and when does it renew?
2. Call the member-services number on your insurance card and ask specifically about fertility preservation, not just IVF. They aren’t the same line item.
3. Ask whether your situation is treated as a medical need.
4. Confirm the cost-sharing. Under SB 729, your deductible, copays, and coinsurance for fertility care have to match what you’d pay for any other condition.

Write down who you spoke to and what they said. If a claim gets denied later, that record is your starting point.

What Fertility Preservation Costs in California (and How to Pay if You’re Not Covered)

Even with the new law, plenty of Californians will pay out of pocket, especially for an elective cycle. So let’s be straight about the numbers, then about the ways to make them manageable.

Out-of-Pocket Costs by Preservation Type

Preservation type	Procedure	Medications	Storage
Eggs	$9,000-$13,000 / cycle	$3,000-$6,000	$500-$1,000 / yr
Embryos (with IVF)	$12,000-$20,000 / cycle	included or + meds	$500-$1,000 / yr
Sperm	A few hundred-$1,000	n/a	Modest annual fee

A few honest notes. Egg medications can run past $6,000 on aggressive protocols (Kaiser quotes up to $8,500). Embryo work rides on an IVF cycle, so Kaiser’s own cycle fee, for instance, lands around $17,400 to $20,600. And if you’re preserving eggs for age-related reasons, one cycle often won’t bank the number you want, which multiplies the total. None of this is meant to scare you off. It’s meant to keep you from getting blindsided.

What Insurance and Employer Benefits May Cover

The picture changes completely if you qualify for infertility insurance coverage. Medical-need preservation on a qualifying SB 729 plan can drop your out-of-pocket cost to little more than a normal deductible and copay, because the law forces fertility cost-sharing to match the rest of your care.

Two other doors are worth checking. First, employer fertility benefits: companies that use programs like Carrot, Kindbody, or Progyny often cover an elective cycle the law doesn’t, so ask even if SB 729 doesn’t apply to you. Second, Medi-Cal: it hasn’t traditionally paid for preservation or IVF and sits outside SB 729, but if you have a medical need tied to cancer care, ask your managed-care plan directly rather than assuming the answer is no.

Financing, Discounts, and Assistance Programs

If you’re paying yourself, you have more fertility financing options than the sticker price suggests:

• Clinic payment plans. Many California programs spread the cost over months or years. UCSF advertises financing from about $150 a month.
• Fertility loans. Specialist lenders like Sunfish finance egg, sperm, and embryo preservation when a clinic plan isn’t enough.
• Multi-cycle packages. If you’re likely to need more than one cycle, bundled pricing usually beats paying per cycle.
• Self-pay discounts. Some programs help patients without coverage; Fertility and Surgical Associates of California, for one, advertises $2,000 off for self-pay patients.
• Cancer-patient grants. Nonprofits like Livestrong Fertility help people facing cancer care, and Triage Cancer keeps a running guide to assistance.

One piece of advice from the inside: don’t shop on price alone. The cheapest single cycle isn’t a bargain if it leaves you with too few eggs and you pay for another. The right plan weighs your odds against the number of cycles you’ll realistically need, which is exactly the math a specialist can do with you.

The Fertility Preservation Process and Timeline in California

Knowing what’s coming takes the edge off. Here’s how the process actually runs, and how fast you may need to move.

How Fast You Need to Act (Especially Before Cancer Care)

If care is on the calendar, speed is everything, and fertility programs know it. Leading California centers see patients within 24 to 48 hours of a cancer diagnosis and work closely with your oncologist so preservation fits around treatment instead of delaying it.

How fast depends on what you’re preserving. Banking sperm can happen the same day. Eggs and embryos need roughly two weeks for the ovaries to respond to medication, though modern “random-start” protocols let that cycle begin almost any day instead of waiting for your period. When even two weeks is too long, ovarian tissue or ovarian protection can step in.

What a Preservation Cycle Looks Like

For eggs or embryos, the path is more predictable than you’d expect:

1. Consult and testing. A reproductive endocrinologist reviews your ovarian reserve (AMH and an antral follicle count) and builds your plan.
2. Stimulation. About 10 to 14 days of hormone injections, with a few short visits for bloodwork and ultrasounds.
3. Retrieval. A short procedure under light sedation, usually under 30 minutes.
4. Store. The eggs are vitrified that day, or fertilized first if you’re making embryos, then stored.

Banking sperm skips most of this: you provide a sample, the lab stores it, and you’re done. Either way, a board certified reproductive endocrinologist owns the plan, so you’re not navigating it alone.

How Long You Can Store and Use What You Preserve

Once stored, your eggs, sperm, and embryos can wait. There’s no firm expiration date on properly preserved tissue, and people come back to use it years later through IUI, IVF, donor programs, or surrogacy. You’ll pay an annual storage fee while it waits.

When you’re ready, that stored material becomes the starting point for a personalized treatment plan built around the family you want. The hard part is behind you. This is the payoff.

You’re One Conversation Away From Your California Fertility Preservation Plan

You came here to protect something simple and enormous: the chance to have kids on your own timeline. By now you know your real options, you have a sense of which one fits, and you’ve seen that California’s laws may cover more than you expected, especially if care is coming. The hard part to do alone is fitting all of it to your body, your budget, and your deadline.

That’s what a first conversation with us is for. At CCRH , a board certified reproductive endocrinologist will go through your options and check exactly what your coverage includes, then build a fertility preservation plan around your life and your timeline. Our team pairs deep expertise in reproductive medicine and reproductive endocrinology with the support that makes a hard decision easier: clear answers on fertility services and fertility treatments, financial guidance, emotional support, and counseling when you need it. 

Book a consultation with us and let’s keep your options open while you still have the window.

 

If you and your partner are starting to map out fertility testing costs, a semen analysis is usually the first step, and the first thing most men want to know is what it’ll cost. The honest answer on semen analysis cost: $50 to $300 across most of the country, with $150 to $250 being typical out of pocket. Some cash labs go as low as $30.

The average isn’t really the problem, though. The same basic procedure can run $90 at one center and $400 at another, and whether your insurance helps is a coin toss until you call and ask. So this guide breaks down what you’ll spend by type of test, when insurance actually steps in, and how to keep from overpaying before you book. The price matters, but as you’ll see, what you do with the result matters more.

How Much Does a Semen Analysis Cost?

A standard semen analysis sits in the middle of that range for most people, but the spread is real: as little as $50 at the low end and $300 or more at the high end. The reason is that the term covers everything from a quick sperm count to a multi-part workup. The breakdown below shows where your money actually goes.

 

The Standard Price Range

A standard semen analysis looks at three things: sperm concentration (the count), how well the sperm move (motility), and the volume of the sample. That basic version is what most centers quote first, and it usually lands between $50 and $300. You’ll be asked to abstain from ejaculation for a few days first, and to mention any medications, so the sample reflects your real sperm health. The results themselves are a topic of their own, so here’s what you can learn from a semen analysis if you want the full rundown.

Where you fall in the range depends mostly on where you go, which we’ll get to in a minute. For the real-world spread: men on fertility forums report owing as little as $35 when it went toward a deductible, and as much as $400 at a private center for nothing more than the basic exam. Cash marketplaces like MDsave list it for around $30 to $47.

What Each Type of Test Costs

The base figure only covers the basics. Add-on tests each carry their own fee, and they stack fast. Here are the common ones as typical out-of-pocket amounts, though you should confirm locally since labs charge differently:

Test	Typical self-pay fee
Basic semen analysis (count + motility)	$65 to $141
Analysis with morphology	$125 to $268
Antisperm antibody (immunobead)	$150 to $182
Post-ejaculatory urinalysis	$150 to $229
Sperm cryopreservation	$100 to $150
Frozen sperm storage (per year)	$180 to $360
Sperm DNA fragmentation	$300 to $500+

Most couples starting out only need the basic analysis, sometimes with morphology added. Advanced testing like sperm DNA fragmentation is ordered separately, usually only when there’s a known problem or a history of miscarriage, and it’s never folded into the base figure.

How Much Prices Vary by Clinic and Location

This is the part that catches people off guard. The same basic procedure, with no extras, can cost four times as much across town. One man in Michigan found an office charging $75 while another nearby wanted $300. In Colorado, labs run $75 to $200, plus a $60 referring physician order fee on top.

A few things drive the gap:

• Type of place. Independent and university labs tend to be cheapest, hospitals sit in the middle, and private fertility centers charge the most.
• Your area. Local cost of living and how many providers compete nearby both move the figure.
• What’s bundled. Whether the doctor’s fee to review your results is included or billed separately.

The takeaway: rates are shoppable. Contact two or three places across your area, find a testing site that quotes clearly, and ask for the all-in cash figure before you commit.

Why Semen Analysis Costs Vary So Much

If a $90 quote and a $400 quote both just say “semen analysis,” what are you actually spending extra on? Four things, mostly.

Facility Type

Where you get tested matters more than almost anything else.

• Independent and university andrology labs are usually cheapest, often $65 to $150. You get a result sheet, but not always someone to explain it.
• Hospital labs sit in the middle and bill through hospital coding, which can complicate what you owe.
• Private fertility centers charge the most, commonly $200 to $500, but the figure usually includes a specialist reading your results and a clear next step if something’s off.

A higher figure isn’t automatically a markup. You’re often spending on the lab’s quality and the specialist’s expertise, which a bare result sheet doesn’t give you.

How Many Parameters Are Tested

Every measurement you add raises the bill. A basic count-and-motility procedure might be $65 to $141. Add morphology, which is the shape of the sperm, and you’re looking at $125 to $268. Antisperm antibody testing is roughly another $150. Sperm DNA fragmentation can add $300 to $500 on its own.

The catch: most first-time testing only needs the basic analysis, maybe with morphology. Focus on that first. Paying for the full panel upfront is the most common way men overspend on a workup they didn’t need yet.

Lab Technology and Accuracy

Some labs analyze your sample by hand under a microscope. Others use computer-assisted semen analysis (CASA), which costs more to run and can nudge the figure up. Neither is automatically more accurate for a basic procedure, but it’s worth knowing what you’re spending on.

The question actually worth asking is whether the lab is CLIA-certified. That tells you it meets federal quality standards, which matters far more than microscope versus machine.

The Hidden Interpretation or Consultation Fee

This is the charge that turns a $150 quote into a $250 bill. Some centers quote you the lab fee but bill separately for a doctor to interpret the results, or for a consultation you’re required to book. Colorado labs, for example, often add a $60 physician order fee.

Before you book, ask one direct question: does this figure include the doctor reviewing my results, or is that billed on top? It’s the easiest way to avoid a surprise at the desk.

Does Insurance Cover a Semen Analysis?

Sometimes. Often not. It depends on your plan and why you’re testing, and plenty of couples cover the cost themselves even with decent insurance. Our full guide to infertility insurance coverage breaks down plan types and mandates, but here’s the short version for a semen analysis specifically.

When It’s Usually Covered

Coverage is most likely when a referring physician orders the test as medically necessary, usually after about 12 months of trying to conceive without success, or for post-vasectomy confirmation. A referral helps, because it gets the procedure coded as diagnostic rather than elective.

State rules matter too, but less than you’d hope. Only about 15 states have infertility mandates, and roughly 7 of those exclude male-factor testing entirely. So even in a mandate state, your semen analysis isn’t guaranteed to be covered. Broader expansions like California’s SB 729 IVF coverage mostly apply to large-group plans starting in 2026, not a diagnostic procedure like this one.

Why Many Couples Still Pay Out of Pocket

Even with coverage on paper, the bill often lands on you. The usual reasons:

• High-deductible plans. The test counts toward your deductible, so you owe the full amount yourself anyway.
• Fertility exclusions. Some plans don’t cover anything fertility-related.
• Testing too early. Before the 12-month mark or a formal diagnosis, insurers may call it elective.
• Out-of-network centers. Many fertility practices don’t contract with insurers at all.

If you’re covering it yourself, $150 to $250 is normal. It doesn’t mean you’re being overcharged. One thing worth checking: if your employer offers a fertility benefit through a platform like Carrot, it may cover testing even when your medical plan won’t.

Self-Pay, Superbills, and Reimbursement

A lot of centers, especially dedicated andrology labs, won’t bill your insurance directly. Instead they hand you an itemized receipt called a superbill, which you submit to your insurer yourself for possible reimbursement.

When you call to book, ask these four things:

• Is the doctor’s interpretation included in the figure?
• Will you bill my insurance, or give me a superbill to submit?
• What’s the cash figure?
• What CPT code will you use? Your insurer can tell you if that code is covered.

How to Pay Less for a Semen Analysis

You have more control over this bill than it looks. A few moves cut what you spend without cutting corners on the result.

Compare Self-Pay Quotes the Right Way

A “$99” quote isn’t cheaper if it leaves out morphology and the doctor’s read, then bills those separately. A “$200” all-in quote can easily come out ahead. So compare like for like.

When you call around, check the same four points each time:

• Which parameters are included: count, motility, morphology?
• Is the physician’s interpretation part of the figure?
• What does a second test cost if you need one?
• Is there a separate order or consultation fee?

Cash-Pay Marketplaces and Diagnostic Labs

The cheapest routes skip the fertility center entirely. Cash marketplaces like MDsave list a semen analysis for around $18 to $47. Independent and university andrology labs run about $65 to $150.

The trade-off: you get a raw result with no one to interpret it, and a sperm count on its own tells you very little about what to do next. That usually means a separate doctor visit later. This works best if you already have a provider lined up to read the numbers. If you don’t, the savings disappear once you add that visit, and you’re back to needing the guidance a fertility center was going to give you anyway.

At-Home Kit Cost vs Clinic Cost

At-home mail-in kits feel cheaper, but the gap is smaller than you’d expect. A kit runs roughly $150 to $225 (Coastal Fertility’s kit is $225 and includes a telehealth consultation), while in-office self-pay sits around $150 to $300. You collect the sample at home, follow the kit instructions, and ship it back to the lab, which delivers your results online. Once you add shipping, a kit often lands right in office territory.

The real risk is a do-over. These kits are built for men unable to collect at a lab, but if an at-home result comes back borderline, you’ll likely need an in-office analysis to confirm it anyway, so the cheapest option upfront can end up costing more.

HSA, FSA, and Financing

A semen analysis is a qualified medical expense, so you can use an HSA or FSA. That’s pre-tax money, which effectively takes 20% to 35% off the figure depending on your tax bracket. Just keep the itemized receipt.

If the procedure is part of a larger fertility workup, some centers offer fertility financing options through services like CareCredit, and fertility-specific lenders like Sunfish can help you spread the cost out. Worth asking about if you’d rather pay over time.

Is a Semen Analysis Worth the Cost?

For a procedure that runs $150 to $250, it’s one of the highest-value things you can do early in a fertility journey. Here’s why.

What That Price Actually Buys You

Male-factor infertility plays a role in about 40% to 50% of couples who struggle to conceive. Skip testing the man and you’re ignoring half the picture, sometimes for months.

For a couple hundred dollars, a semen analysis can save you exactly that: months of guessing, and the far larger cost of treatments like IUI or IVF, where you can pay for a full egg-retrieval cycle chosen before anyone knows what’s going on. A specialist can read the numbers, determine what’s behind a low result, and identify the next step toward conception, whether that’s a lifestyle change, ordinary treatment, or a procedure like sperm extraction when no sperm show up in the sample at all. The reference ranges define what fertile men typically look like, so the result tells you both where your reproductive health stands on the path to pregnancy. Testing both partners early is the efficient way to spend your money.

Budgeting for a Possible Second Test

Sperm counts swing naturally from week to week, so one result rarely tells the whole story. If the first test comes back off, your doctor will likely order a second test a few weeks later to confirm it before recommending any treatment. That’s another $65 to $268, depending on what’s performed.

It’s not an upsell, it’s standard practice. Budget for two rounds from the start and a repeat won’t catch you off guard.

Get a Semen Analysis and a Clear Path Forward

Quick recap. A semen analysis costs $50 to $300, and most couples spend $150 to $250 out of pocket. The figure swings on what’s tested and where you go, insurance is a maybe until you ask the right questions, and comparing all-in quotes plus an HSA or FSA keeps you from overpaying.

But the number on the invoice was never really the point. A bare result sheet from the cheapest lab tells you almost nothing on its own. What you’re actually after is an answer: is everything fine, and if not, what now? That comes from a specialist who reads your numbers in context and tells you the next step, whether that’s a simple lifestyle change, a second test, or a fuller fertility workup.

That’s where a fertility center earns its place. At California Center for Reproductive Health, your semen analysis isn’t a one-off transaction, it’s the first step in a guided plan, with transparent pricing upfront and a specialist who walks you and your partner through what the results actually mean. Book your appointment with our expert fertility team and start with a real answer instead of another bill.

Most people searching for fertility test costs expect a simple number. There isn’t one. “Fertility testing” is not a single procedure. It is a collection of separate tests, each measuring a different aspect of reproductive health, each priced differently depending on the type, the facility, and whether insurance applies.

Blood tests sit at the cheaper end: typically $50 to $200. Imaging and structural tests run higher, often $200 to $1,500 or more. Both partners have their own set of relevant tests, and a complete couple’s workup can total anywhere between a few hundred dollars and over $2,500.

This guide covers every major female and male fertility test with current price ranges, what each one measures, how insurance can reduce what you pay, and what a full evaluation actually costs when you add it all up.

Female Fertility Tests and What Each Costs

Female fertility testing covers several different procedures, each looking at a distinct part of the reproductive picture. Here is a quick overview before we go into each one in detail.

Test	What It Measures	Cost	Timing	At-Home?
AMH blood test	Egg supply (ovarian reserve)	$50–$200	Any time in cycle	Yes
FSH blood test	Ovarian reserve indicator	$50–$150	Day 2–3 of cycle	No
Antral follicle count (AFC)	Active follicles in ovaries	$200–$400*	Day 2–5 of cycle	No
Saline sonogram	Uterine cavity structure	$200–$500	After period, before ovulation	No
HSG	Fallopian tube patency	$500–$1,500+	Day 7–10 of cycle	No

*AFC is frequently bundled into the initial clinic consultation fee rather than billed separately; ask before assuming it is an add-on.

Anti-Müllerian Hormone (AMH) Blood Test

AMH is produced by the follicles in your ovaries. The level in your blood reflects the size of your remaining egg supply, what doctors call ovarian reserve. Higher AMH suggests a larger egg supply; lower AMH points toward diminished ovarian reserve.

Clinic cost is typically $50 to $200. At-home kits from brands such as Modern Fertility bring it toward the lower end of that range: you draw a finger-prick sample and mail it in. No special cycle timing is required, which makes this the easiest test to start with.

Follicle-Stimulating Hormone (FSH) Blood Test

FSH is the hormone your brain sends to stimulate egg development each cycle. When ovarian reserve is low, the brain increases FSH output to compensate; an elevated FSH reading is a sign that your egg supply may be diminishing.

Cost ranges from $50 to $150, and it is often ordered alongside an estradiol (E2) test for a fuller picture. The catch: it must be drawn on day 2 or 3 of your menstrual cycle. Miss that window and you wait until the next one.

Antral Follicle Count (AFC) via Transvaginal Ultrasound

An AFC uses a transvaginal ultrasound to count the small resting follicles visible in both ovaries at that point in the cycle. Each follicle represents a potential egg. Because it shows what is physically present in the ovaries right now, many specialists consider it the most direct measure of ovarian reserve.

If billed as a standalone procedure, expect $200 to $400. In practice, most fertility clinics include it in the initial consultation. Spring Fertility does this alongside a physician review and medical history discussion, so check before paying for it separately.

Saline Sonogram (Uterine Cavity Evaluation)

A saline sonogram involves instilling sterile saline through the cervix to outline the uterine cavity on ultrasound. The goal is to detect structural abnormalities: polyps, fibroids, scar tissue, or anything else that could prevent an embryo from implanting even when ovarian reserve is perfectly normal.

The procedure takes about 10 minutes and is done in a clinic. Mild cramping is common. Cost typically runs $200 to $500 depending on the clinic and whether it is bundled. It is most relevant for anyone preparing for IVF or IUI, or who has experienced recurrent pregnancy loss.

Hysterosalpingogram (HSG) for Fallopian Tube Assessment

An HSG uses a low-dose X-ray and radio-opaque dye injected through the cervix to show whether the fallopian tubes are open or blocked. The result has a direct impact on treatment cost: open tubes keep less expensive options like IUI on the table; blocked tubes mean IVF is the required path.

Without insurance, an outpatient HSG typically runs $500 to $1,500. Hospital-based radiology departments can charge $3,000 or more for the same procedure. The good news is that because HSG is classified as a diagnostic procedure (not fertility treatment), many insurance plans cover it. Check your coverage before assuming it is out of pocket.

Male Fertility Tests and What Each Costs

Male factor infertility contributes to roughly half of all cases where a couple struggles to conceive. Testing both partners from the start avoids months of one-sided investigation; male testing is also usually the least expensive part of the entire workup.

Test	What It Measures	Cost (Clinic)	Cost (At-Home)
Semen analysis	Sperm count, motility, morphology	$50–$300	$50–$200
Male hormone panel	FSH, LH, testosterone, prolactin	$100–$400	Not available

Semen Analysis

A semen analysis measures three things: sperm count (how many), motility (how well they move), and morphology (whether their shape is normal). Together, these tell you whether sperm are likely to reach and fertilize an egg.

At a clinic or fertility lab, the cost runs $50 to $300. At-home kits from brands such as Legacy or YO are available for $50 to $200 and measure count and motility, though a full clinical analysis provides more detailed morphology data that at-home kits cannot match.

The sample is collected after 2 to 5 days of abstinence and results typically come back within a few days. A normal result is strong evidence that male factor issues are not a concern. Abnormal results (low count, poor motility, or irregular morphology) are the trigger for the next step.

Male Hormone Panel

A hormone panel is not usually the first test ordered for men. It typically follows an abnormal semen analysis to investigate why the numbers are off.

The panel covers:

• FSH: reflects how well the testes are producing sperm
• LH: signals sperm production at the hormonal level
• Testosterone: low levels directly suppress sperm development
• Prolactin: elevated levels can interfere with fertility

Cost runs $100 to $400 depending on which hormones are tested and whether they are ordered individually or as a panel. Identifying a hormonal cause matters because some conditions respond to medication, which can improve sperm parameters without moving straight to IVF.

How Much Does a Complete Couple’s Fertility Workup Cost?

A full evaluation for both partners covers separate tests across bloodwork, imaging, and semen analysis. The table below shows what each component typically costs without insurance.

Component	Tests Included	Typical Cost
Female bloodwork	AMH + FSH	$100–$350
Female imaging	AFC + saline sonogram + HSG	$900–$2,300
Male semen analysis	Standard clinic analysis	$50–$300
Male hormone panel	FSH, LH, testosterone, prolactin	$100–$400 (if needed)
Couple's total		$600–$2,500+

The range is wide because the same test carries a very different price tag depending on where you have it done. An HSG at an outpatient fertility clinic in a mid-size city might cost $400 to $600. The same procedure at a hospital-based radiology department in a major metro can run $1,500 to $3,000. Always get a quote from your specific clinic before building a budget around any midpoint figure.

Not everyone needs every test. A healthcare provider will narrow the list based on your age, cycle history, medical history, and overall health. Your actual out-of-pocket fertility test cost could be considerably lower than the full total above.

If you want to start testing without going straight to a fertility clinic, there are a few lower-cost options worth knowing:

• OB/GYN-ordered bloodwork: AMH and FSH can be ordered by a regular OB/GYN and billed as routine diagnostic lab work, often covered by standard insurance without a fertility referral or specialist visit
• Walk-in labs: Labcorp OnDemand and Walk-In Lab offer AMH testing for roughly $100 to $150, no doctor’s visit required
• Planned Parenthood: Some locations offer hormone testing at reduced cost for those who qualify based on income
• Bundled consultations: Many fertility clinics include a transvaginal ultrasound with AFC alongside the physician consultation and medical history review for a single initial fee; Spring Fertility structures it this way, which typically works out cheaper than ordering those tests individually

One more thing worth knowing: if fertility treatment follows your diagnostic workup, the costs from that evaluation are generally not billed again as part of treatment. The workup is the first step in a continuum, not a separate expense stacked on top.

At-Home Fertility Tests: What They Cost vs. What You Get

At-home fertility testing has improved significantly. The tests are real, the results are meaningful, and the cost is lower than a clinic visit. Here is what you get for the money, and where the limits are.

Test Type	What It Measures	Cost
Female hormone panel (AMH, FSH, LH, estradiol)	Ovarian reserve indicators, cycle hormones	$50–$200
Ovulation predictor kits	Whether ovulation is occurring	Under $20
Male semen analysis kit	Sperm count and motility	$50–$200

What At-Home Tests Can Tell You

At-home tests give you a useful baseline. A hormone panel can flag a low AMH result that is worth investigating further. Ovulation predictor kits confirm whether ovulation is happening on a regular cycle. A male semen analysis kit can identify low sperm count or motility before either partner has set foot in a clinic.

That information has real value. Catching an abnormal result early means a faster path to answers and earlier access to treatment options.

What At-Home Tests Cannot Tell You

There are four things no at-home test can assess:

• Antral follicle count: Requires a transvaginal ultrasound
• Fallopian tube status: Requires an HSG at a radiology or fertility clinic
• Uterine cavity health: Requires imaging to detect polyps, fibroids, or scar tissue
• Full sperm morphology: At-home kits measure count and motility; detailed morphology analysis requires a lab

If the question is whether to try at-home first or go straight to a clinic, age and history are the deciding factors. At-home testing makes sense if you are under 35, have regular cycles, have no known reproductive health history, and are not yet ready to commit to a clinic visit. Skip straight to the clinic if either partner is over 35, cycles are irregular, there is a history of PCOS, endometriosis, or prior to cancer treatment, or you have already been trying without success for several months.

At-home tests are a lower-cost first filter, not a replacement for a full clinical workup. A normal at-home result does not rule out the structural issues that only imaging can find.

Does Insurance Cover Fertility Testing?

Insurance coverage depends on your plan, your state, and how the tests are coded. Here is a breakdown of what is commonly covered and how to reduce what you pay out of pocket.

Coverage splits roughly along diagnostic vs. fertility-specific lines:

• AMH and FSH bloodwork: Often covered when ordered by an OB/GYN under standard diagnostic codes, not flagged as fertility-specific
• Semen analysis: May be covered as a routine diagnostic lab test depending on the plan; worth checking before paying out of pocket
• Transvaginal ultrasound and AFC: More variable; some plans cover diagnostic imaging, others require prior authorization or deny fertility-related ultrasounds outright
• HSG: Commonly covered because it is classified as a diagnostic radiology procedure rather than fertility treatment; prior authorization is often required, so call before scheduling

Coverage also varies significantly by state. Several states mandate insurance coverage for fertility diagnostics or treatment; most do not. Call your insurer and ask specifically whether each test is covered under diagnostic codes or fertility codes. That distinction alone can determine whether you pay $0 or $1,500 for the same procedure.

How to Reduce Out-of-Pocket Fertility Testing Costs

Even without comprehensive insurance, there are several ways to bring the total down significantly before you set foot in a clinic.

Start With Your Regular Doctor

An OB/GYN can order AMH and FSH bloodwork and bill it as routine diagnostic lab work. No fertility referral is needed, and it is far more likely to be covered under a standard health plan than the same tests ordered at a fertility clinic. For many people, this is the lowest-cost entry point into fertility testing: you get the two most informative hormone markers for potentially nothing out of pocket, and you only move to a specialist if those results warrant it.

Walk-in labs such as Labcorp OnDemand and Walk-In Lab offer AMH testing for $100 to $150 without a doctor’s visit at all, which works well if you want a quick baseline before any clinic appointment.

Ask About Billing Codes Before Every Test

How a test is coded on your insurance claim often determines whether it is covered. Fertility-specific codes are denied far more frequently than general diagnostic codes. The same transvaginal ultrasound or HSG can be billed under a diagnostic code (covered) or a fertility code (denied), and that choice is made by the ordering physician at the point of billing.

Before any imaging or procedure, ask your doctor whether they can use general diagnostic codes where medically accurate. This is not manipulating the system; it is correct coding when the clinical reason is diagnostic. It matters most for HSG, transvaginal ultrasound, and AFC.

Compare Facility Prices Before You Schedule

The same procedure carries very different price tags depending on where it is performed. An HSG at an outpatient fertility clinic might cost $400 to $700. The same procedure at a hospital-based radiology department in the same city can run $1,500 to $3,000. Call two or three facilities and ask for an itemized estimate before you book.

For bloodwork, prices vary significantly between facilities too. A lab draw ordered through your OB/GYN and processed through a commercial lab is typically cheaper than the same panel drawn and processed at a specialty fertility clinic.

Use FSA and HSA Accounts

Fertility diagnostic tests are FSA and HSA eligible. That means you are paying with pre-tax dollars, which effectively reduces your out-of-pocket cost by your marginal tax rate. For someone in the 22% bracket, a $500 HSG costs closer to $390 in real terms.

Bundled initial consultations are also worth asking about directly. Many fertility clinics include the physician consultation, medical history review, and transvaginal ultrasound with AFC in a single initial fee. That package is almost always cheaper than ordering those components separately, and it gives you a full picture in one visit.

If treatment costs become a factor beyond testing, platforms like Sunfish aggregate fertility grants, loans, and discounts in one place and are worth reviewing before assuming the full expense falls on you. If out-of-pocket costs remain a concern, our fertility financing options can help spread the expense across time.

Check Your Employer Benefits

Fertility benefits are increasingly common as a workplace perk, and they can cover diagnostic testing costs entirely, independent of your standard health insurance. Platforms like Carrot allow employers to offer fertility benefits that employees can apply directly to testing and treatment. Some employers partner with clinic networks like Kindbody to provide covered fertility care as part of their benefits package.

Check your HR portal or benefits documentation before assuming fertility testing is fully out of pocket. If your employer uses either of these platforms, you may have access to funding that bypasses standard insurance restrictions altogether.

When Should You Get a Fertility Test?

Standard clinical guidelines give you a starting point, but they are not the only trigger worth knowing about.

The baseline recommendations by age:

• Under 35: See a doctor after 12 months of trying without success
• Ages 35 to 40: After 6 months
• Over 40: Proactive evaluation before you start trying, or immediately upon starting

These guidelines assume you have no known risk factors and regular cycles. If either of those is not true, the timeline shortens regardless of age.

Get tested earlier if any of the following apply to either partner:

• Irregular or absent menstrual cycle
• Diagnosed or suspected PCOS or endometriosis
• Prior cancer treatment (chemotherapy or radiation can affect ovarian reserve and sperm production)
• Family history of early menopause
• Known or suspected male factor history

You also do not need to be actively trying to conceive to justify testing. Anyone considering egg freezing, or who simply wants to understand their baseline before starting to try, can get tested now. The cost of a diagnostic workup is fixed; the cost of delayed treatment is not. Finding out your ovarian reserve is lower than expected at 32 is a very different situation from finding out at 38.

When you do decide to test, starting with a semen analysis is often the fastest and cheapest first step for couples. It is non-invasive, results come back quickly, and it rules out male factor issues before anyone undergoes more involved procedures. Both partners testing at the same time gives you the full picture from the start and avoids working through one side sequentially only to discover the other was the primary issue.

The Bill for Waiting Grows Faster Than You Think

Ovarian reserve declines with age, and that decline accelerates after 35. A woman with borderline reserve at 32 may have significantly diminished reserve at 36. The window for less invasive treatment options closes faster than most people expect.

The cost of fertility treatment rises sharply with each step up the ladder:

• Timed intercourse: No cost.
• Intrauterine Insemination (IUI): $1,000 to $3,000 per cycle.
• IVF: $15,000 to $25,000 per cycle.
• Donor egg IVF: $40,000 or more.

Each step up is triggered by a narrowing window. Testing early keeps the cheaper rungs within reach. Waiting until conception has not happened for a year or more can mean skipping several of those rungs entirely.

Couples who test proactively and find normal results lose nothing except a few hundred dollars and gain a clear baseline. Couples who wait and discover a problem later consistently say the same thing: not that the outcome would have been different, but that earlier knowledge would have meant more options.

Schedule an appointment at our clinic to find out where you stand before time decides for you.

Surrogacy in California costs $120,000 to $200,000 or more. The first question most intended parents ask is a simple one: how much can health insurance cover?

California Senate Bill 729 changes that calculation. Understanding what SB 729 surrogacy coverage includes, and where it stops, can shift how you budget and plan before your first clinic appointment.

The law does not cover your surrogate’s compensation, agency fees, or legal costs, but it covers more of the fertility clinic portion than most intended parents realize, and that difference matters when you are looking at six-figure total costs. This guide focuses specifically on what SB 729 means for intended parents working with a gestational carrier, including what’s covered, what’s not, who qualifies and how to check coverage with your insurance.

What SB 729 covers for intended parents pursuing surrogacy

Senate Bill 729 requires fully insured large group health insurance plans to provide coverage for the diagnosis and treatment of infertility and fertility services, including the in vitro fertilization process used to create embryos for transfer to a gestational carrier. The intended parent’s treatment of infertility is what the law covers, not the surrogate’s medical care.

Certain health insurance plans are required by law to offer coverage for infertility services, including fertility treatments for intended parents working with a gestational carrier. Insurers cannot use an insurance contract to deny fertility services based on a covered individual’s participation in fertility services provided by or to a third party. A surrogate or gestational carrier qualifies as that third party. If your health plan qualifies, the presence of a surrogate is not a valid reason to deny a covered health care service.

Under a qualifying large group plan, the law requires insurers to cover the following:

• Diagnostic testing and infertility evaluation, including review of your medical and reproductive history.
• Fertility medications, including injectable hormones and other prescription medications used throughout the IVF process; insurers cannot apply different cost-sharing rules to fertility drugs than to other prescriptions.
• Egg retrieval, up to three completed retrievals for the intended parent.
• Embryo creation via in vitro fertilization, including fertilization procedures.
• Embryo transfer to the gestational carrier, with unlimited embryo transfers covered (one at a time, when single embryo transfer is medically appropriate per ASRM guidelines).

To put that in dollar terms: a single IVF cycle costs $15,000 to $25,000 out of pocket without IVF coverage. Senate Bill 729 can cover the fertility care and medically necessary treatment at the fertility clinic. That is the fertility clinic bill, not the surrogacy arrangement as a whole.

The fertility clinic steps that Senate Bill 729 should cover in your surrogacy journey

Most intended parents come to their first consultation with a rough sense of what surrogacy costs in total. Fewer know exactly which line items on the fertility clinic’s side of that bill their health insurance is expected to cover. This section walks through each fertility treatment step in order.

Pre-treatment evaluation and diagnostic testing

Before embryo creation begins, the intended parent goes through a full fertility evaluation at the clinic. Depending on your situation, this includes bloodwork, hormonal panels, ultrasounds, uterine cavity assessment, and semen analysis if the intended father’s sperm is being used.

The senate bill requires coverage for this evaluation phase. Under the law, a licensed physician’s findings from a review of your medical history and other clinical factors constitute the covered infertility assessment. This evaluation is not a separate billable item that falls outside the mandate.

Many intended parents assume this workup comes out of pocket. Under a qualifying plan, it should be covered. Confirm with your insurer before your first appointment so there are no surprises on the explanation of benefits.

 

Egg retrieval, fertilization, and embryo creation

The IVF cycle to create embryos involves ovarian stimulation with fertility medications, monitoring appointments, the egg retrieval procedure itself, fertilization (using ICSI or standard in vitro fertilization), embryo development in the lab, and optional preimplantation genetic testing.

SB 729 covers up to three completed egg retrievals under qualifying large group plans. Each completed retrieval counts toward that limit. Fertility medications throughout this process must be covered on the same terms as other prescription medications; your insurer cannot create a separate, higher cost-sharing tier specifically for fertility drugs.

One nuance that matters for gay male couples and some intended mothers: if you are using a donor’s eggs rather than your own, coverage for the donor’s retrieval is not automatically guaranteed under the law. The mandate covers the intended parent’s own fertility treatments and infertility services; donor agency fees and donor compensation are explicitly excluded. If donor egg IVF is part of your plan, ask your insurer specifically whether they will cover IVF using donor eggs and get the answer in writing before the cycle begins.

Embryo transfer to the gestational carrier

This is the step where the embryo, created from the intended parent’s or donor’s genetic material, is transferred to the surrogate’s uterus. Under the law, this procedure is classified as part of the intended parent’s infertility treatment, not the surrogate’s medical care.

The legal principle here is plain: the law prohibits insurers from denying coverage for fertility services provided by or to a third party, and a gestational carrier qualifies as that third party. The surrogate’s role in the treatment of infertility does not give the insurer grounds to deny the procedure.

Unlimited embryo transfers are covered under qualifying health plans (one per attempt, when single embryo transfer is medically appropriate per ASRM guidelines). If the first attempt does not result in a pregnancy, additional transfers are covered within your plan’s terms without requiring a new egg retrieval cycle, provided viable frozen embryos remain.

What SB 729 does not cover in a surrogacy journey

The senate bill is a genuine expansion of fertility coverage rights in California. It also comes with clear coverage limitations, and intended parents are better served knowing those limits upfront than discovering them mid-process.

The law does not require insurers to cover the surrogate’s costs or the non-medical elements of the surrogacy arrangement. Here is what falls outside the mandate:

• Gestational carrier compensation, typically $40,000 to $60,000 or more.
• Surrogacy agency fees, typically $20,000 to $35,000 or more.
• Legal fees for drafting and executing the surrogacy contract.
• The gestational carrier’s prenatal care, delivery, and obstetric costs, which require a separate health insurance policy for the surrogate.
• Newborn hospital expenses.
• The surrogate’s insurance premiums, which intended parents typically pay out of pocket as part of the surrogacy arrangement.

Even with SB 729 covering the fertility clinic portion, intended parents should budget at least $100,000 in additional costs overall. The law reduces what you pay at the fertility clinic. It does not restructure the surrogacy financial model.

That framing matters when you are planning. The law’s insurance coverage is most valuable in the early clinical phases: the diagnostic workup, the IVF cycle, and the embryo transfers. Those are real savings. The larger cost drivers in surrogacy sit outside the insurance mandate entirely.

Does your health insurance plan qualify under SB 729?

The coverage the law provides is real, but it only applies if your specific plan falls within its scope. Two intended parents at different companies, both in California, can have very different answers to this question.

Plans that must provide surrogacy-related fertility coverage

The law applies to fully insured large group health insurance plans covering 101 or more employees. “Fully insured” means the insurance company bears the financial risk of paying claims, as opposed to self-funded health plans where the employer pays claims directly.

If your employer is headquartered outside California but you are a California resident, the plan must still comply. Location of the employer does not create an exemption; coverage of California residents does.

Timing matters too. Most health insurance plans do not automatically switch on January 1, 2026. SB 729 coverage takes effect at your plan’s first renewal date on or after January 1, 2026, expanding health insurance coverage for fertility treatments at that point. Depending on when your employer’s plan renews, your health insurance coverage may begin mid-2026.

Small group health insurance policies work differently. Insurers are required to offer coverage for infertility as an option, but it is not automatic. It may require an additional rider that your employer has to elect. If you are on a small group plan, ask HR whether that option was chosen.

The law requires insurers to provide the same infertility benefits regardless of marital status, gender identity, or domestic partner status. All qualifying health plans must apply these insurance protections equally. Certain health insurance plans cannot impose different terms or conditions based on any of those characteristics.

Plans exempt from SB 729 requirements

Self-funded employer plans are the most consequential exemption. According to the KFF 2025 Employer Health Benefits Survey, approximately 67% of covered workers in the US are enrolled in self-funded arrangements. That means the majority of people with employer-sponsored insurance are on plans that California’s mandate cannot touch, because self-funded employer plans are governed by federal ERISA law, not state insurance law. Verify this with HR before assuming the law applies to you.

Level-funded plans are a common hybrid that trips up many intended parents. In a level-funded arrangement, the employer self-funds claims up to a stop-loss threshold and uses an insurer for costs above that. From the employee’s perspective, it often looks and feels like a standard insured plan. Whether the new insurance protections under SB 729 apply depends on how the plan is legally classified. Do not assume from your plan materials alone. Ask HR the specific question: “Is our plan fully insured, self-funded, or level-funded?”

Other exempt plan types include:

• Federal health plans, including TRICARE and federal employee benefit programs.
• Public employee health plans, including CalPERS (exempt until July 1, 2027).
• Certain religious employers and religious organizations with qualifying exemptions.
• Medi-Cal managed care plans.
• Specialized healthcare service plan contracts.
• Disability insurance policies issued outside California’s large-group framework.

If your plan falls into any of these categories, talk to your fertility clinic about self-pay pricing and whether any partial insurance coverage applies. Many fertility clinics have experience navigating coverage for patients on exempt plans.

Who qualifies under the new Senate Bill 729 infertility definition

The senate bill did not just expand what insurers must cover. It changed the definition of infertility under California law. That change matters most for the people who need surrogacy as a path to parenthood.

The old definition and why it left many intended parents unprotected

Before SB 729, the insurance definition of infertility in California required proof of 6 to 12 months of unprotected intercourse failing to result in pregnancy. On its face, that sounds like a clinical standard. In practice, it excluded a large portion of the people who pursue surrogacy.

Gay male couples cannot meet an intercourse-based test by definition. Single individuals cannot either. Women who have had a hysterectomy, those with congenital uterine anomalies, and those with recurrent pregnancy loss from uterine causes are not going to produce a pregnancy through intercourse regardless of how long they try. Under the old definition of infertility, insurers could deny all of them coverage because they did not satisfy the intercourse requirement. The law recognized inability to conceive through intercourse, not a person’s inability to carry a pregnancy or reproduce without medical intervention.

The new definition and who it now covers

The new definition of infertility under Senate Bill 729 can be established through a licensed physician’s findings from a clinical assessment: a review of medical history and other relevant factors the physician identifies.

There is no intercourse requirement. The law recognizes that a person’s inability to reproduce alone or with a partner without medical assistance is sufficient grounds for a diagnosis. A physician’s finding to that effect is what qualifies a patient for coverage, not a record of failed attempts at intercourse.

For intended parents pursuing surrogacy, this directly benefits:

• Single individuals who want to use a gestational carrier
• Same-sex couples, to whom no intercourse-based test applies
• Women with uterine factor infertility, including those who have had a hysterectomy, experienced DES exposure, have a congenital uterine anomaly, or have experienced recurrent pregnancy loss from uterine causes
• Cancer patients and others whose medical treatment affects fertility, including those who have undergone chemotherapy or radiation; the law explicitly covers individuals undergoing medical treatment that affects their ability to reproduce, including those who need fertility preservation before cancer treatment begins

SB 729 protections for LGBTQ+ intended parents pursuing surrogacy

For LGBTQ+ families, and particularly for gay male couples who need both an egg donor and a gestational carrier, the senate bill represents a meaningful shift in the insurance protections available for fertility treatments.

The law’s anti-discrimination provisions are explicit. Insurers cannot deny infertility coverage based on sexual orientation, gender identity, or domestic partner status. These are not general principles; they are written into the statute as requirements. An insurer applying different terms or benefit structures to an LGBTQ+ intended parent than to a heterosexual married couple is in violation of California law.

The third-party provision extends those new insurance protections into the surrogacy context. SB 729 explicitly covers fertility services that involve sperm donors, egg donors, and gestational carriers. A gay male couple’s intended parent can use their qualifying health insurance for the fertility clinic portion of surrogacy: the egg retrieval, fertilization, and the transfer procedure to the surrogate. The same infertility benefits that apply to any other covered patient apply to them.

Before the law changed, an insurer could deny an LGBTQ+ intended parent on the grounds that they had not attempted intercourse or did not meet the prior definition of infertility. That gap is now closed. CCRH has served LGBTQ+ families throughout its 20+ years in practice. This is a patient population the clinic knows well, and one that now has stronger legal coverage protections than at any point in California’s history.

How to confirm your SB 729 coverage before starting surrogacy

The steps below apply to most fertility insurance plans, but going in prepared saves time and prevents surprises once treatments are underway.

1. Ask HR one question first: “Is our health insurance plan fully insured, self-funded, or level-funded?” This determines whether the law applies at all. If you do not know the answer, you cannot assume insurance coverage exists. Get this answer before anything else.
2. If your plan is fully insured and covers 101 or more employees, ask for your plan’s first renewal date on or after January 1, 2026. Your health insurance coverage under the law starts then, not when the senate bill passed.
3. Ask specifically about infertility and IVF coverage: “Does our plan offer coverage for the diagnosis and treatment of infertility, including IVF and embryo transfer procedures, under SB 729?” General confirmation that the plan “covers fertility” is not enough. You want confirmation of the specific infertility services.
4. Ask about third-party coverage: “Does the plan cover fertility services that involve a third party, such as a gestational carrier or surrogate?” Some insurers comply with the general IVF mandate but have not updated their claims processing to reflect the third-party provision. Ask directly.
5. If you are using donor eggs, ask a separate question: “Does the plan cover IVF using donor eggs?” The mandate covers the intended parent’s own fertility treatments; donor egg coverage varies by plan and is not automatic under the law.
6. Get all confirmations in writing. An email from HR or a written statement from the insurer protects you if a claim is later disputed. Verbal confirmation does not.
7. If you receive a denial, request the specific reason in writing. If the insurer is denying coverage because a surrogate is involved, or citing your sexual orientation or marital status, that denial may violate California law. A fertility clinic experienced in insurance disputes can help you understand your options.

Our team can help you review your benefits and understand what your health insurance policies cover before treatment begins. Bringing your insurance information to your initial consultation means you can ask specific questions and get clarity before any cycle begins.

 

Talk to a surrogacy-experienced fertility team today

Here is what the law means in practice for intended parents pursuing surrogacy:

• When your plan qualifies, SB 729 covers the intended parent’s diagnostic workup, egg retrieval, embryo creation, embryo transfer, and fertility medications
• LGBTQ+ intended parents have explicit anti-discrimination protections; the law prohibits denying infertility coverage based on sexual orientation, gender identity, or domestic partner status
• The expanded definition of infertility means more people qualify for treatment of infertility, including those who need surrogacy due to uterine factor, prior cancer treatment, or same-sex partnership
• Self-funded ERISA plans and level-funded plans may be exempt; verify your plan type with HR before assuming SB 729 coverage applies

Surrogacy means coordinating between an agency, a surrogate, and a fertility clinic at the same time. CCRH guides intended parents through the medical side of that process, and our team can help you make sense of your coverage options at your initial consultation.

With over 20 years serving Los Angeles-area families, a dedicated LGBTQ+ fertility program, and comprehensive gestational surrogacy services, we advise intended parents on their fertility treatment options and the infertility services available at the clinic. Schedule an appointment with one of our specialists today to discuss your surrogacy options and how to use your SB 729 benefits.

If you’re planning IVF in California, SB 729 changes the financial picture in a real way. But knowing the law exists is not the same as knowing what it actually pays for.

California’s SB 729 is the broadest expansion of fertility insurance the state has ever seen. It requires many employer health plans to provide coverage for in vitro fertilization and related fertility services at a level no prior California law has matched. For patients who have been navigating the high cost of IVF and other fertility treatments on their own, that is genuinely welcome news. But not every plan qualifies, not every procedure is included, and your coverage may not start when you expect.

This article goes procedure by procedure through what the SB 729 IVF mandate covers, what it excludes, who qualifies, and what to do before your first appointment.

What IVF procedures SB 729 requires insurers to cover

Up to three completed egg retrievals

SB 729 requires covered plans to pay for up to three completed oocyte retrievals per covered individual. Prior to this law, California had no mandate requiring insurers to cover IVF at this level, and most patients were paying for cycles entirely out of pocket.

The word “completed” matters here. A completed retrieval is a full stimulation and egg retrieval cycle, regardless of how many eggs are actually retrieved. If a cycle results in few or no viable eggs, it still counts toward the three-cycle limit. Patients should be aware of this when planning how to use their covered cycles.

The three-retrieval limit applies per person, not per pregnancy attempt. That means you can use all three covered retrievals to bank embryos before doing any transfers, a strategy some patients pursue to maximize the number of embryos available before implantation.

Unlimited embryo transfers

Once embryos exist, the law places no cap on the number of transfers a covered individual can receive. The IVF coverage mandate includes unlimited embryo transfers, which means frozen embryo transfers (FETs) from all three covered retrieval cycles, including any embryos previously banked, remain covered as long as you stay on a qualifying plan.

Transfers must follow guidelines from the American Society for Reproductive Medicine (ASRM), which generally recommend single embryo transfer when clinically appropriate. This is a clinical guideline, not a punitive restriction: it reflects the medical evidence on reducing multiple pregnancies while protecting patient outcomes.

Fertility medications, monitoring, and anesthesia

The mandate covers the full scope of medications associated with an IVF cycle: gonadotropins for ovarian stimulation, trigger shots, progesterone support, and other prescription medications tied to the cycle. Insurers cannot apply different restrictions to fertility medications than they do to other prescription medications: no special tiers, no higher cost-sharing for IVF drugs specifically.

Cycle monitoring and diagnostic testing are included: ultrasounds, hormone level bloodwork, and the lab work that tracks your response to stimulation. These monitoring appointments are a routine part of every IVF cycle and are covered as part of the mandate, not billed separately.

One question that comes up often and rarely gets a direct answer: anesthesia for the egg retrieval is covered under SB 729 as part of the retrieval procedure itself. You do not pay out of pocket for anesthesia on top of a covered cycle.

What SB 729 does not cover in your IVF cycle

SB 729 is a major step forward for fertility access in California. But it has specific gaps, and patients who assume the mandate covers everything in their IVF cycle are likely to encounter billing surprises mid-treatment. Knowing what falls outside the mandate before you start is just as useful as knowing what’s included.

ICSI and genetic testing are not mandated benefits

ICSI (intracytoplasmic sperm injection) is used in the majority of IVF cycles in the United States, but it is not an explicitly mandated benefit under SB 729. The law’s diagnosis and treatment mandate covers IVF itself, not every adjunct procedure. If your infertility diagnosis involves male factor infertility or your clinic recommends ICSI for other clinical reasons, confirm directly with your insurer whether your specific insurance plan covers it. Some plans will include ICSI voluntarily, because SB 729 sets a floor for coverage, not a ceiling. Do not assume it is covered without written confirmation.

The same applies to preimplantation genetic testing. PGT-A (for aneuploidy screening), PGT-M (for monogenic diseases), and PGT-SR (for structural rearrangements) are not mandated benefits under the law. For patients pursuing genetic testing before transfer, this is a meaningful out-of-pocket cost to plan for. Before starting a cycle, ask your insurer specifically about ICSI and PGT coverage and get the answer in writing.

Elective egg freezing versus medically necessary fertility preservation

SB 729 does cover medically necessary egg freezing, but only when there is a documented medical indication. The clearest example is fertility preservation before cancer treatments: if a patient needs chemotherapy or radiation that could affect ovarian function, the egg retrieval and freezing associated with that preservation is covered under the mandate.

What is not covered is elective egg freezing for personal or social reasons: career timing, relationship status, or simply wanting to preserve options for the future. That distinction matters for younger patients who may be considering egg freezing proactively. The egg retrieval component of a medically necessary preservation cycle may be covered; a purely elective freeze without a documented medical indication falls outside the mandate.

If you are unsure whether your situation qualifies as medically necessary, a consultation with a reproductive endocrinologist is the right starting point.

Third-party reproduction: donors, gestational carriers, and surrogacy services

SB 729 explicitly prohibits insurers from denying coverage solely because a donor, gestational carrier, or surrogate is involved in treatment. That anti-discrimination protection is real and meaningful for LGBTQ+ patients and single parents pursuing family building through donor or surrogacy pathways.

But that protection is different from mandating coverage of third-party costs. Donor agency fees, donor compensation, gestational carrier screening, surrogacy coordination, and legal fees are not part of the mandated benefit. The covered services are for the intended recipient: the stimulation, retrieval, and transfer procedures performed on or for that patient.

In a donor egg IVF cycle, the intended parent’s clinical services (embryo transfer, monitoring, medications) may still be covered. How costs are split between the donor’s portion and the recipient’s portion varies by plan and by clinic billing practices. Your fertility clinic’s financial team can walk you through what to expect before you begin.

Who qualifies for IVF coverage under SB 729

The expanded definition of infertility: who now qualifies for IVF under the law

One of the most underreported changes in this senate bill is not about what procedures are covered, but about who is recognized as having infertility in the first place.

Prior California law largely tied the infertility definition to heterosexual intercourse: a patient needed to demonstrate failure to conceive after a specified period of unprotected sexual intercourse. That standard excluded same-sex couples, single individuals, and anyone who could not or did not reproduce through intercourse with a partner.

SB 729 changes that. The law now recognizes infertility through three pathways, expanding access to the diagnosis and treatment of infertility for patients who previously could not qualify. First, a licensed physician’s findings based on a patient’s medical or reproductive history and physical findings. Second, a person’s inability to reproduce without medical intervention, whether alone or with a partner. Third, failure to establish pregnancy after the standard intercourse-based period, for those to whom that pathway applies.

In practice, this means LGBTQ+ individuals and same-sex couples can obtain an infertility diagnosis and qualify for IVF coverage without having to meet a heterosexual intercourse requirement. Single parents by choice qualify on the same basis. The law explicitly prohibits discrimination based on marital status, gender identity, sexual orientation, domestic partner status, national origin, and other protected characteristics.

For patients who have historically been told they do not “meet the definition” of infertility for insurance purposes, SB 729 represents a direct correction to that exclusion.

Employer plan requirements: large group and fully insured

Qualifying personally is one half of the eligibility picture. The other half is whether your employer’s health plan is covered by the mandate.

SB 729 applies to fully insured large group health plans regulated by the California Department of Managed Health Care (DMHC) or the California Department of Insurance (CDI). “Large group” means the insurance plan covers 101 or more employees. Both HMOs and PPOs in this category must comply. Certain health insurance plans from out-of-state employers with 101 or more employees who provide coverage to California residents are also subject to the mandate, provided the plan is fully insured and state-regulated.

If both of those conditions apply to your plan, and your plan has renewed on or after January 1, 2026, IVF coverage should already be in effect.

Plans exempt from the SB 729 IVF mandate

SB 729 applies only to fully insured plans. Self funded plans, where the employer directly pays health claims rather than paying premiums to an insurer, are governed by federal ERISA law, and California’s mandate does not apply regardless of where you live or work. If your employer’s plan is self-funded, some companies independently offer fertility benefits through platforms like Kindbody or Carrot. Ask your HR department whether your employer has added any voluntary fertility benefits beyond what state law requires.

Other exempt categories include: small-group plans covering fewer than 101 employees, individual market plans, Medi-Cal, Medicare, dental or vision-only plans, accident-only policies, and qualifying religious organizations.

The small-group situation has a nuance worth knowing. SB 729 requires insurers to offer coverage for infertility services to small-group employers, but small employers are not required to purchase or include it. There is a real difference between an insurer being required to offer fertility benefits and an employer being required to include them.

The fastest way to find out where you stand: ask your HR department two questions. Is our health plan fully insured or self-funded? And when does our plan renew? Those two answers will tell you whether SB 729’s IVF mandate applies to your health care coverage and, if so, when it takes effect.

When your SB 729 IVF coverage actually begins

The January 1, 2026 effective date and plan renewal timing

SB 729 became California law effective January 1, 2026, but that date is not when every eligible patient gained coverage. The actual start of your IVF benefits depends on when your employer’s health plan renews, not on the law’s effective date.

Here is how it works: plans that renewed on or after January 1, 2026 must include SB 729 coverage at that renewal. A plan that renewed on January 1 has had the mandate in effect since the start of the year. A plan that renews in July will add IVF coverage in July. All fully insured large-group plans must comply no later than December 31, 2026, so by the end of this year every qualifying plan should be in compliance.

The practical implication: some patients already have IVF coverage under this senate bill. Others are still waiting for their plan’s renewal date. If you are unsure where your plan stands, the answer is in your benefits documentation or your HR department, not in the law’s effective date alone.

State employees and CalPERS: a delayed timeline

If you are a California state employee covered through CalPERS, your timeline is different. IVF coverage under SB 729 does not begin for CalPERS members until July 1, 2027. A separate California state budget provision delayed CalPERS compliance beyond the general January 2026 effective date.

This is not a minor footnote. State employees planning IVF around expected insurance coverage need to account for this gap. If you are a CalPERS member and your plan has not yet renewed with SB 729 benefits, your IVF costs remain self-pay or subject to whatever fertility benefits your current plan already includes.

Should you start IVF now or wait for SB 729 coverage?

This is one of the most common questions patients ask once they learn about SB 729, and it deserves a straight answer rather than a deflection.

The financial case for waiting is real. IVF covered by insurance costs a fraction of what patients pay out of pocket. If your plan renewal is three months away and coverage will include up to three egg retrievals, the savings are substantial. Nobody should be told to simply ignore that.

But there is a clinical variable that does not wait for insurance calendars: age. Ovarian reserve and egg quality decline over time, and that decline accelerates after 35. A six-month delay in starting IVF is not a neutral decision for every patient. For someone with diminished ovarian reserve, advancing age, or a diagnosis that affects fertility over time, waiting for coverage can meaningfully affect how many viable embryos a retrieval produces, and ultimately how many transfer attempts are possible.

The right decision depends on your specific fertility care needs and medical picture, not on a general rule. For some patients, starting a retrieval cycle now and using SB 729 coverage for future cycles once it activates is the better clinical call. For others, a short wait is low-risk and the financial benefit is worth it.

At CCRH, we evaluate each patient’s fertility care needs, including ovarian reserve, reproductive history, and overall timeline, before making any recommendation about when to begin treatment. A consultation gives you the clinical information you need to weigh that decision clearly, rather than making it based on the insurance calendar alone.

How to use your SB 729 IVF benefits: steps to take before your first appointment

Confirm your plan type and renewal date with HR

Before anything else, contact your HR department or benefits administrator and ask two specific questions: Is our health plan fully insured or self-funded? And what is our plan’s renewal date?

If the answer is fully insured and your health insurance plan has renewed since January 1, 2026, IVF coverage under SB 729 should already be active. Ask for written documentation confirming the mandate is part of your current benefit summary. Do not rely on a verbal confirmation. Having it in writing protects you if a claim is later disputed.

If your plan is self-funded, or your renewal date has not yet passed, SB 729’s IVF mandate does not yet apply to you. That does not mean IVF is out of reach. At CCRH, patients in this situation have access to various fertility financing options, including through Sunfish, which offer flexible monthly plans without hard credit checks. Your path to treatment does not depend entirely on whether your employer’s plan qualifies under the mandate.

Understand your out-of-pocket responsibilities under the mandate

SB 729 requires your insurance provider to provide coverage for IVF and related infertility and fertility services. It does not eliminate what you owe. Deductibles, copays, and coinsurance still apply, and these vary considerably from one plan to the next.

Before your first appointment, contact your insurer and get specific answers on the following: your deductible and whether IVF costs apply toward it, your cost-sharing for fertility services based on how your plan classifies them, how fertility medications are tiered on your formulary, and whether lab fees and facility fees are billed separately. Some plans apply IVF costs to the same deductible as all other health care services. Others carry a separate fertility deductible. Reviewing these coverage details upfront prevents the kind of billing surprises that disrupt treatment mid-cycle.

Get your infertility documentation in order before requesting authorization

Most insurers require a documented infertility diagnosis from a licensed physician before they will authorize IVF under SB 729. While the law requires plans to cover infertility diagnosis and treatment, prior authorization is not automatic. Assuming it is can delay your start date by weeks.

Your physician can establish infertility through several pathways recognized under the law: findings based on your medical or reproductive history and physical findings, documented inability to reproduce without medical intervention, or the standard intercourse-based period where applicable. For LGBTQ+ patients and single individuals, the physician documentation pathway described in the “Who qualifies” section above satisfies the insurer’s prior authorization requirement. No intercourse history is needed.

Schedule a diagnostic consultation at a fertility clinic before submitting a prior authorization request. At CCRH, our team works with patients directly on the documentation process, helping ensure the clinical record is complete and the authorization request is submitted correctly the first time.

Your IVF benefits are ready: use them

SB 729 mandates IVF coverage and broader infertility treatment for patients on fully insured large-group plans in California, effective since January 1, 2026. That means up to three completed egg retrievals, unlimited embryo transfers, fertility medications, cycle monitoring, and anesthesia for retrieval. These are the core assisted reproductive technology services in a standard IVF cycle. Coverage depends on your specific plan type and your employer’s renewal date. Procedures like ICSI and PGT are not explicitly mandated. Elective egg freezing is not covered; medically necessary fertility preservation is. And if you are LGBTQ+ or a single parent by choice, SB 729 explicitly includes you.

Understanding where this law applies to your specific plan type is the essential first step. Whether your plan now covers IVF or you are still waiting on a renewal date, get the clinical information you need to make a plan. At CCRH, our team helps patients verify their fertility insurance coverage, understand what their plan actually pays for, and build a treatment plan that accounts for both their medical picture and their financial situation.

SB 729 makes fertility care and infertility diagnosis and treatment more accessible to more California families than ever before. We have been helping patients pursue fertility treatments and build their families for over 20 years, delivering fertility services with or without insurance coverage. We are ready to help you figure out exactly where you stand and what comes next.

Schedule an appointment at our clinic to confirm your IVF insurance coverage, review your treatment options, and take the first step on your family building journey.